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Breast cancer research aims to develop a detailed understanding of the underlying 
mechanisms of disease progression and to generate approaches to improve early 
detection, monitoring, and treatment of breast cancerous lesions. The success of current 
standardized breast cancer therapies varies as each breast cancer patient and tumor is 
different and unique whereas the standard of care is based on specific breast cancer 
patient cohorts. To further current clinical success, the characteristics of each tumor mass 
must be considered. Such an individualized or personalized approach is incompatible 
with current understanding of “average” breast cancer tumors and responses to 
treatments. Thus, the long-term objective of the present research is to develop modular 
breast tissue models to (1) further our understanding of individual breast cancer tumors 
and (2) monitor and develop customized treatment plans, thus contributing to breast 
tissue and breast cancer research. 
The main goal of this project was to develop a three-dimensional (3D) breast 
tissue in vitro test system using tissue-engineering concepts. The model is uniquely 
different from existing models in that it accounted for extracellular matrix (ECM) 
heterogeneity through use of an ECM hydrogel embedded with polylactide beads. 
Furthermore, the 3D model was used to specifically investigate the effect of 
heterogeneity of the mammary microenvironment on normal human mammary epithelial 
cells (MCF10A) and human breast cancer cells (MCF7). Specifically, (1) polylactide 
beads with various physicochemical features were produced and characterized, (2) an 
 
 iii 
ECM hydrogel representing the stromal component was evaluated and selected, and (3) a 
3D tissue engineered composite system with and without polylactide beads containing 
either MCF10A or MCF7 cells was used to investigate the effects of microenvironment 
heterogeneity. Development of a benchmark 3D breast tissue model, where cellular 
interaction can be studied in an environment that is more representative of the native 
tissue, helps researchers better understand cell reactions and behaviors in breast cancer. 
This model allows the rapid assessment of therapies as well as controlled studies of basic 
breast cancer processes and mechanisms. The outcome of this research was the 
generation of a 3D in vitro breast tissue model that better mimics specific influences of 
the ECM in breast tissue and breast cancer progression. 
While the scientific merit of the proposed work was to advance the understanding 
of breast tissue development and early breast cancer stages, the goal was to reach outside 
the breast cancer community to share the work and progress. Further, the second 
objective of this research was to reach out to young scientists and engineers through an 
undergraduate introductory research program, highlighting interdisciplinary approaches 
in scientific endeavors. This initiative broadened the intellectual merit of the project and 
introduced ideas related to breast cancer research in other related fields of research, 
thereby generating additional in-depth research opportunities and advancements in the 
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Breast cancer is the most prevalent malignant disease of women in the developed 
world, apart from skin cancer, with approximately 1 in 8 women in the United States 
being diagnosed with breast cancer during their life times [1]. Breast cancer begins when 
normal mammary epithelial cells grow, divide and form a cell mass, which then invades 
surrounding tissue and eventually leads to metastasis. Much research using breast tissue 
models has been conducted to understand how cells become cancerous in the mammary 
gland, propagate, and eventually metastasize in the body. While this research has 
provided a better understanding of the underlying mechanisms associated with normal 
mammary gland function and breast cancer, our understanding of the extracellular matrix 
(ECM)-cell interactions during normal breast tissue and malignant development remains 
unclear. Model systems currently in use include clinical and in vivo models, two-
dimensional (2D) in vitro models, and three-dimensional (3D) in vitro culture models. In 
recent years, 3D model systems have been developed for numerous normal tissues and 
pathologic conditions. Ranging from the use of tissue tumor explants to cell lines in 
homo or heterotypic cultures, 3D in vitro culture systems provide information on the role 
of mesenchymal cells, the matrix composition, and density in the formation of acinus- 
and duct-like structures. However, the need for reliable, versatile, and reproducible 3D in 
vitro model systems that allow the modulation of the ECM properties remains. Therefore, 
3D in vitro mammary culture may provide further understanding of breast tissue growth 
and malignant development. Furthermore, standardization of such culture systems may 





To understand how this disease develops and how normal mammary epithelial cells 
transform into cancerous cells, the development of a modular breast tissue model system 
was used to study the cellular interactions and the mammary microenvironment. 
This research focuses on the development of a new 3D heterogeneous in vitro 
breast tissue model. The model was engineered as a complex tissue, with normal and 
cancerous mammary epithelial cells embedded within a 3D matrix. Acinus- and duct-like 
mammary structure formation within the 3D system was assessed to determine how ECM 
heterogeneity affects structure formation. The matrix structure in vitro was controlled 
using combinations of natural and synthetic biomaterial substrates to mimic the 
heterogeneous stiffness of the normal mammary tissue. In these conditions, the behavior 
of the normal and cancerous mammary epithelial cells in response to heterogeneity 
changes was monitored. The ability to control the phenotypic changes of normal and 
cancerous mammary epithelial cells provided a means for improved understanding of in 
vivo conditions and the effect heterogeneity plays during breast formation. As the cell-
cell and cell-ECM interactions [2] play a large part in breast formation and mammary 
tumor progression, developing a benchmark 3D breast cancer model to study these 
interactions provides a new research tool to further our understanding of breast 
development and mammary malignant growth. Such a model may also be relevant in 
clinical diagnostic, therapeutic, and monitoring applications. This model is not meant to 
replace existing models, but to radically enhance our understanding of the normal breast 
and breast cancer microenvironment, thereby allowing development of more efficient 





The next chapters cover the research conducted, which includes two components: 
development of a 3D in vitro breast tissue model and understanding how involvement of 
undergraduate students in Science, Technology, Engineering, and Mathematics (STEM) 
disciplines in research helps them develop a research identity. The overall research 
objective is to establish a new 3D breast tissue model composed of polylactide (PL) 
beads embedded in a hydrogel and to determine behavior of normal and cancerous 
mammary epithelial cells in the presence of increased microenvironment heterogeneity. 
Chapter 2 discusses polylactide bead fabrication and characterized. In Chapter 3, the 
hydrogel matrix material, representative of the stromal component of the breast, for the 
3D in vitro breast tissue model was determined. The stromal component was selected 
based on cell viability and acinar-like structure formation. Portions of results in Chapter 3 
were generated by an Institute for Biological Interfaces of Engineering interdisciplinary 
team, including Clemson University undergraduate student Devleena Kole, and were 
presented at the 2013 Annual Meeting and Exposition of the Society For Biomaterials: 
McCave EJ, Kole D, Burg KJL: Development of a Heterogeneous In Vitro Three-
Dimensional Breast Tissue Model. In: Society For Biomaterials 2014 Annual Meeting 
& Exposition: 2014 (Denver, CO; 2014) [3]. The laboratory research concluded in 
Chapter 4 where the composite 3D model system was generated and evaluated to 
determine effects of heterogeneity on cells. Mechanical properties of the 3D breast tissue 
model, composed of hydrogel matrix material alone or hydrogel containing PL beads, 
were characterized. Further, normal human mammary epithelial (MCF10A) or human 





proliferation, protein expression, and function determined. This 3D model will enhance 
understanding of the role of mammary microenvironment in the function of normal 
mammary epithelial cells and in early stages of mammary cancer progression. 
The educational portion of this project, Chapter 5, focuses on research identity 
development through participation in research programs. Minority undergraduate 
students from Clemson University and the University of North Carolina Charlotte 
participated in one semester of the National Science Foundation: Emerging Frontiers in 
Research and Innovation (NSF:EFRI) – Research Experience and Mentoring (REM) 
program. Students were introduced to research focused on developing different 3D 
culture methods for normal and breast cancer research. The REM program was students’ 
first exposure to research and focuses on developing necessary skills for students to 
succeed in future research within their own majors. Students were paired with a mentor 
on the mentor’s project. Beyond the laboratory skills gained through the experience, 
different professional development topics, such as “introduction to research”, “how to 
conduct research”, “how to read scientific articles”, “how to produce a standard operating 
procedure”, and “exploration of career paths”, were discussed with the students. A joint 
10-week summer Research Experience for Undergraduates (REU) was offered to four of 
the participating REM students and helped the students further develop their research 
identity by building their research skills and providing them with the opportunity to 
develop an independent research project. Results in Chapter 5 were generated by an 
Institute for Biological Interfaces of Engineering interdisciplinary team and co-written 





2014 Northeastern Biomedical Engineering Conference McCave EJ, Gilmore JA, Burg 
TC, Burg KJL: Evaluation of an Introductory Research Program for Minority 
Student in an Interdisciplinary Tissue Engineering Lab. In: 40th Annual Northeast 
Bioengienering Conference (NEBEC): 2014; Boston, MA: IEEE; 2014 [4] and the 2014 
American Society for Engineering Education Annual Meeting and Exposition McCave 
EJ, Gilmore JA, Burg KJL: Engineering and Science Student Preparedness for 
Research: Exploring the Connections Between Student Identity and Readiness for 
Research. In: 121st American Society for Engineering Education Annual Conference & 






Portions of this chapter were published in the following review article: McCave EJ, Cass 
CA, Burg KJ, Booth BW: The Normal Microenvironment Directs Mammary Gland 
Development. J Mammary Gland Biol Neoplasia 2010, 15(3):291-299 [6]. 
LITERATURE REVIEW 
Anatomy of the Human Breast 
The human breast is a complex tissue composed of a glandular structure (the 
mammary gland) located on top of the pectoral muscles of the chest [7], consisting of a 
nipple, lobes, and ducts, surrounded by stromal tissue, fibrous and fatty tissue. The 
mammary gland is a dynamic structural tissue that changes with stages in life, beginning 
with the formation of the lobule bud structure during neonatal development, continuing 
with the development of alveoli or acini during adolescent puberty, then full lobulo-
alveolar development with child birth, followed by involution at the end of lactation [8]. 
Each breast contains 15-20 lobes of glandular tissue [7, 9] that branch into smaller 
lobules which are subdivided into the secretory alveoli for milk production (Figure 1.1). 
Each lobule has an excretory ductal system that converges to form the lactiferous ducts 
which exit through the nipple; just behind the nipple the lactiferous ducts widen to create 
reservoirs called lactiferous sinuses [7]. The stroma, i.e. the fatty and connective tissue, 
surrounds the lobes of the glandular tissue and is connected to the chest wall by Cooper’s 
ligaments which help shape the breast [7]. Lymph nodes, responsible for draining the 
lymph fluids from the breast, are present in five major areas surrounding the breasts, and 





organisms, and abnormal cells [9, 10]. The breast contains very little muscle and is 
mainly composed of stroma, which defines the shape and size of the breast [7, 9, 11]. 
 
 
Figure 1.1 A schematic of the anatomy of the female breast. The glandular structure is 
surrounded by fatty connective tissue. The enlargement demonstrates the lobule structure 
and the normal excretory ductal structure [12]. 
Ductal Tissue and Structure 
The glandular ducts consist of luminal epithelial cells associated with myo-
epithelial cells and surrounded by a basement membrane (BM) that connects the 
glandular tissue to the stroma of the breast [13]. In early mammary gland formation in 
utero, the mammary placodes formed in the ventral skin of the embryo through epithelial-





gland. The functional unit of the gland, the acinar shaped ducts [15, 16], are lined with a 
single layer of luminal epithelial cells which are associated with a layer of alveolar myo-
epithelial cells, which are stellate shaped and form a basket-like structure around the 
acinus [17]. Although approximately 20% of the luminal epithelial cells do directly 
contact the BM, the remainder are adjacent to myo-epithelial cells [18]. Polarity is a 
fundamental property of epithelium, allowing the surfaces of the cells and tissues to 
divide into apical and baso-lateral areas, where cell-cell contact and cell-extracellular 
matrix (ECM) interactions determine the asymmetric architecture and polarity, resulting 
in directionality of protein localization and appropriate function of the organ during 
lactation [19]. 
During adolescent puberty, the distal ends of the rudimentary ducts enlarge to 
form club shaped lobular structures, called terminal end buds (TEB), which contain 
highly proliferative cells [14]. The TEB (Figure 1.2) have a basally located monolayer of 
cap cells at their tip that move to the proximal part of the duct and differentiate into myo-
epithelial cells [17], which act similarly to smooth muscle cells and aid in contraction 
during lactation [15, 20, 21]. Breast epithelial stem cells, found throughout the ductal 
structures, are thought to be responsible for continuous cell renewal, growth, and 
branching throughout the reproductive period, as well as the massive epithelial expansion 
seen during pregnancy [21]. As the ductal tree forms, repeated dichotomous branching 
proceeds, creating the tubes that deliver milk to the nipple, while lateral buds develop 
along mature ducts and are constrained by the lack of open territory of the surrounding 





called lobules [15], which continue to develop with new budding of structures with each 
ovulatory cycle [23]. 
 
 
Figure 1.2 Cross-section through end bud with accompanying diagram. End buds are 
bilayered structures; an outer layer of myo-epithelial progenitor cells (cap cells) overlays a 
multilayered mass of luminal cells fated to form the walls of the ductal lumen (L). Stained 
with hematoxylin and eosin. Original magnification approx. ×300 [22]. 
The breast tissue attains its maximum development during pregnancy and is 
characterized by proliferation of the ductal tree and further development of the existing 
lobules as a result of increased cell number due to cell division and in cell size due to 
cytoplasmic enlargement. The second half of pregnancy is characterized by progressive 
branching with less bud formation and the formation of true secretory acini 
(differentiated structures) [23]. Even with creation of the lobulo-alveolar structures 
during gestation, the onset of milk secretion by the alveolar cells does not occur without 
progressive biochemical and structural differentiation [15]; thus, not all lobulo-alveolar 






The stroma, composed of the fibrous connective tissue and adipose (fatty) tissue, 
comprises approximately 80% of the resting breast volume and is composed of 
fibroblasts, epithelial cells, adipocytes (fat cells), blood vessels, inflammatory cells, nerve 
cells, and a macromolecular network of proteoglycans and glycoproteins, such as 
laminin, fibronectin, elastin and collagen [13, 24], which contribute to the extracellular 
matrix (ECM) [11]. The stroma is composed of two types of ECM. The first is the 
basement membrane (BM), which consists primarily of collagen IV, laminins, 
entactin/nidogen, and heparan sulfate proteoglycans; the second is the interstitial matrix, 
which consists primarily of collagen I and III and fibronectin, which contribute to the 
mechanical strength of the tissue [25]. The stroma is thought to be critical in the 
characteristic shaping of the branching structure of the mammary gland [8] through 
localized activity of transforming growth factor beta (TGFβ). In the branching area of the 
ductal structure, TGFβ is absent, hence its inhibitory effects on epithelial cell 
proliferation and production of ECM-degrading enzymes do not occur, which allows the 
basement membrane to undergo remodeling and promoting cell proliferation and 
branching morphogenesis [24]. As the gland continues to develop, the area occupied by 
the epithelium increases at the expense of the surrounding stromal tissue, which does not 
necessarily mean the loss of stromal cell numbers, but rather a rearrangement of the 
existing stromal cells and tissue elements [15]. The mature mammary fat pad consists 
primarily of adipocytes coupled with developing epithelium that is encased in fibrous 





mature gland [8]. The BM and stroma influence the apoptotic (programmed cell death) 
behavior of the epithelial cells during involution and during menopause, by producing 
enzymes that degrade and rearrange the BM of the mammary gland resulting in a pre-
pregnancy-like glandular structure [8, 15, 23, 26]. 
Breast Development 
The development of the breast correlates to changes in size, shape, and function 
which are associated with the stages of infantile growth, puberty, pregnancy, lactation, 
and menopause [23]. 
Newborn 
Female children are born with small breasts consisting of a nipple and an 
undeveloped system of ducts which exit at the nipple [9]. Mammary gland parenchyma 
arises from a single epithelial ectodermal bud [26] where the mammary placodes, which 
are surrounded by a primary mesenchyme, give rise to the mammary nipple and the 
underlying ductal tree [8]. The placodes elongate, then sprout into the underlying stroma 
of preadipocytes (composing the mammary fat pad) to form the rudimentary ductal 
system [8, 14]. The breast of a newborn is composed of 6-10 straight ductal structures 
opening into the nipple; the ducts open into primitive lobules in the mammary fat pad 
[26]. The mammary fat pad and ductal structure continue to grow isometrically, keeping 






With the onset of puberty, the mammary ductal development accelerates, showing 
growth in both the glandular tissue as well as the surrounding stroma [26]. The 
reproductive hormones which aid in the glandular ductal structure formation are estrogen, 
which promotes the growth of the gland and ducts, and progesterone, which stimulates 
the development of the milk-producing cells [7]. The glandular tissue increases with the 
growth and division of the ductal system through the TEB [8, 14, 17], or alveolar buds, 
which advance through and to the edge of the fat pad by use of cap cells, i.e. myo-
epithelial cell precursors, which have the ability to clear a “path” through the stromal 
tissue in order for the ducts to advance forward, by channeling the internal force of 
dividing cells in a forward direction [22]. The ducts dichotomously divide as they 
progress through the fat pad, leaving a full ductal tree system that continues to develop 
with each menstrual cycle, until about the 35th year of age [26]. 
Pregnancy 
During pregnancy, the breast attains its maximum development through two 
distinct phases: an early phase of growth, characterized by proliferation of the distal 
elements of the ductal tree that results in formation of new branches and new ductules, 
and a late phase of lobular differentiation, which occurs in the last half of the pregnancy 






Lactation starts after post-partum withdrawal of placental lactogen and sex 
steroids, which appear to prevent the action of prolactin on the mammary epithelium 
[26]. Prolactin, released from the anterior pituitary, stimulates milk production while 
oxytocin, released from the posterior pituitary in response to suckling, causes milk 
ejection from the lactating breast [7]. During lactation, no morphological changes occur 
to the mammary gland, which consists of enlarged lobules and acini with dilated lumina 
[26]. The varied size of the lobules throughout the gland suggests varied activity 
throughout [26]. Milk is synthesized and stored in the lactiferous reservoirs until it is 
needed, although if it is stored for longer than 48 hours, milk production and secretion 
begins to decline [26]. Cessation of lactation following weaning is accompanied by 
massive apoptosis and tissue remodeling, and the gland reverts to a structure resembling 
that before pregnancy [15, 20].   
Menopause 
When a woman reaches menopause, usually in her 50’s, breasts undergo changes 
related to the loss of the reproductive hormones, estrogen and progesterone, causing the 
firm breast tissue to shrink and the amount of fat (adipose) tissue to increase [9]. The 
breasts usually become larger and the connective tissue begins to lose strength, causing 
the breasts to sag [10]. At this stage, it is easier for radiologists to detect breast cancer 






Breast cancer is the second most prevalent malignant disease of women in the 
developed world with approximately 1 in 8 women in the United States being diagnosed 
with breast cancer at some point in their lives [1]. The National Cancer Institute 
estimated in 2010 based on NCI’s SEER Cancer Statistics Review that 207,090 females 
and 1,970 males in the United States would be newly diagnosed with breast cancer in 
2010, while 39,840 and 390 deaths would occur in 2010 [27]. The development of the 
breast and understanding of ductal growth is necessary because 90% or more of 
mammary cancers are ductal in origin [22]. Breast tumors are caused by both genetic 
alterations of the normal mammary epithelial cells and epigenetic factors, such as 
interactions with the stromal tissue microenvironment, which play into the initiation, 
progression, and metastasis of the disease [28-31].    
All normal cells incur many continuous mutations over their lifetime (normal rate 
of mutations); almost all of these mutations will have no functional effect on the cell; 
however, tumor (cancer) cells are usually formed when “two hits” occur somatically in 
the same gene [32]. Cancer stem cells have been identified, from a subset of cancer cells, 
as key components in solid tumor growth as these cells are self-renewing cells 
responsible for maintaining cancer growth and producing differentiated progeny that 
form the bulk of the tumor [33]. However, the search for specific genetic causes of breast 
cancer has elucidated important clues to how cells regulate and turn off specific genes to 





stability, which are relevant to the initiation, progression, and potential metastasis of 
tumors [34]. 
The stromal tissue microenvironment, a source of epigenetic factors, is 
instrumental in tumor initiation and progression [25, 28, 30, 31, 35-37]. Changes in the 
microenvironment, such as ECM remodeling, angiogenesis, lymphatic infiltration, and an 
increase in the number of fibroblasts and myo-fibroblasts have been shown to influence 
tumor progression [28], while cellular signaling proteins such as cytokines, growth 
factors, and proteases secreted from the various cell types in the stroma affect tumor 
invasion and later metastasis of breast cancer primary tumors [35]. Cellular behaviors are 
regulated by complex molecular interactions that involve both positive and negative 
feedback loops, as well as high levels of cellular cross-talk [30]. 
The breast changes with age and reproductive history; these changes are reflected 
at the phenotypic level and at the genomic level [23]. This dynamic state provides a need 
to further study the complexity of breast tissue and the cellular interactions that occur 
during development as well as cancer initiation and progression and use this knowledge 
to develop strategies for cancer prevention and cure. 
Cell, Tissue, and Organ Culture 
Cell and tissue culture began back in the 19th century with the works of Ringer 
and Roux [38], while in 1907 Ross Harrison began by culturing frog neurons using the 
“hanging-drop” method [38, 39]. In 1912, Alexis Carrel took a small fragment from the 
heart of an 18-day-old chick embryo and explanted it on hypotonic plasma; passaging the 





but also continued its rhythmic beat [40]. In the 1950’s animal cell culture became 
routine in the laboratory and lead to the development of the first human cell line, HeLa, 
developed from a cancer patient [38, 41]. These early research endeavors have lead to the 
cell and tissue culture techniques that remain a laboratory staple in biomedical and 
biological research today. 
Types of Culture 
Tissue culture is a commonly used generic term for the in vitro cultivation of 
cells, generally consisting of heterogeneous cultures of crudely disaggregated tissues; 
terms such as organ culture, cell culture, primary explants, and ex vivo propagation all 
concern the in vitro cultivation of cells or tissues [38]. Cell culture, on the other hand, 
usually refers to the isolation and propagation of a homogeneous or heterogeneous 
population of cells (e.g., epithelial cells, fibroblasts, etc.) that originate from either 
primary cells, which have a finite lifespan, or cell lines, immortalized cells which are 
normally derived from transformed or cancerous cells [38]. Primary cells are widely used 
to examine the effects of toxins, infectious agents, and other cellular interactions that 
would not otherwise be feasible in vivo [38]. Cell lines are often used to investigate 
questions in biomedical research because of their immortality and because they are well 
studied and characterized; however, they generally do not have the phenotypic 
characteristics of the cell from which they originated [38]. Early cell lines were 
established from tumor tissue and, as such, possess abnormal growth characteristics [38].  
Organ culture involves ex vivo culture of the whole organ or a significant portion 





interactions and three-dimensional (3D) extracellular architecture [38]. Organ culture is 
important when an ex vivo system requires the original organ architecture; however, 
organ cultures do not normally grow rapidly and are not suitable for studies where large 
numbers of cells are required [38]. While tissue or organ culture have been used 
previously to investigate cellular interactions and determine developmental biology 
processes, two-dimensional cell culture is the prominent laboratory technique used, due 
to the ease of cell propagation on tissue plastic surfaces, ability to produce large 
populations of single cell cultures, and the ability to manipulate the microenvironment for 
research purposes. 
Cell Culture Materials 
Three-dimensional cell culture matrices, also known as scaffolds, were introduced 
to cell culture to overcome the 2D culture limitations [42]. These scaffolds are porous 
substrates that can support cell growth, organization, and differentiation on or within their 
structure [42] and are composed of either naturally derived materials (e.g., collagen type 
I, rBM) or synthetic materials (e.g., polylactide). Such materials should provide a 3D 
support to interact with cells to control their function, guiding the spatially and 
temporally complex multicellular process of tissue formation and regeneration [43]. In 
designing scaffolds, mimicking the natural ECM, an intricate interwoven fiber meshwork 
of collagen and elastic fibers embedded in a highly hydrated gel-like material of 
glycosaminoglycans, proteoglycans, and glycoproteins [42], is attractive, but other 
chemical, physical, and mechanical properties of the scaffold material influence cellular 





scaffold fabrication remains highly challenging as the natural in vivo remodeling process 
that is part of the tissue formation process does not take place in vitro [44]. 
Natural Materials 
There are many naturally derived materials that have been and are currently being 
used in epithelial and breast cancer model systems. Some of the common materials used 
are collagen (most often type I, III, and IV), rBM (e.g. Matrigel™), and decellularized 
mammary gland ECM (MGEM). Emerman and colleagues used floating collagen 
membranes as a substrate for culturing mammary epithelial cells in order to evaluate the 
effects of substrate-induced cell shape on differentiation [45, 46]. Most of these materials 
are naturally found in the ECM and are derived from animal ECM. While these materials 
are natural, provide the necessary structure and properties for cells, and direct the 
macroscopic process of tissue formation, they are not always preferred for tissue 
engineering applications and 3D model systems due to their quick remodeling, 
stimulation of inflammatory response, and high cost. 
Synthetic Materials 
Many different synthetic materials have been used as substrates for tissue 
engineering applications and 3D models. Presently, materials such as poly(lactide-co-
glycolide) (PLG) [47, 48] as sintered microspheres [49, 50] and porous scaffolds [51, 52], 
hyaluronic acid-based (HA) spongy scaffolds [53-56], gelatin sponges [57], polyethylene 
terephthalate (PET) nonwoven fabrics [58], poly(ester amide) (PEA) nonwoven scaffolds 





and many other materials have been used as tissue engineering scaffolds. Each scaffold is 
chosen based on certain criteria: rigid enough to structurally support the tissue, but not so 
stiff that it causes differences in appearance, and biodegrades at a rate consistent with 
tissue growth and proliferation. 
Types of Culture Models 
Numerous model systems have been developed in order to evaluate normal 
mammary epithelial tissue formation and function as well as tumor formation and 
progression. Normal human mammary epithelial cells have been cultured in order to 
compare their behavior with that of breast cancer cells, to investigate molecular 
mechanisms underlying any determined differences, and also to examine the effect of 
manipulating the microenvironment on cellular behavior [62]. Currently, animal or 
human in vitro models, in vitro cell culture systems, and animal genetic knockout mice 
are used to investigate many different in vivo tissue processes [63]. 
2D vs. 3D 
Two-dimensional models were first developed, but do not represent the three-
dimensional nature of tissues and organs; however, our ability to understand tissue 
formation, function, and pathology has often depended on 2D monolayer culture, organ 
culture, or animal model systems [64, 65]. Monolayer culture is normally performed on 
2D surfaces such as micro-well plates, tissue culture flasks, Petri dishes, or glass slides 
[42] and has been used to evaluate cell morphology, growth, differentiation, gene 





Even though monolayer culture has provided substantial understanding of normal 
cell morphology and phenotypic expression and allowed evaluation of therapeutic cancer 
drugs [70-72], there are limitations. Cells dissociated from their normal tissues and 
maintained on tissue culture plastic or glass substrates rapidly lose their normal and 
differentiated characteristics despite the presence of nutrients from medium and essential 
hormones [45]. Another major limitation of 2D monolayer culture is the lack of stroma, 
which is important when modeling breast cancer since stroma of the mammary gland 
accounts for more than 80% of the resting breast volume [2]. The ECM and its 
components are pivotal in determining cell phenotype and function, especially in the 
mammary gland [73].  
Three-dimensional cultures provide a well-defined geometry, which makes it 
possible to directly relate structure to function, they can be composed of representative 
cell combinations (for example, proliferating, non-proliferating, and necrotic cells), and 
they can support co-cultivation of multiple cell types in order to study the interaction 
between cell types and their surrounding matrix [2]. Overall, 3D models have emerged as 
powerful tools to investigate fundamental cellular and biophysical mechanisms that have 
not been readily amenable to traditional genetic or biochemical analysis [74]. 
Animal Models 
A number of different approaches have been taken to model early breast cancer 
progression though the use of murine models. Research methods include the induction of 
premalignant lesions, the generation of genetically engineered mice that are susceptible to 





transformed, transduced with oncogenic viruses, or transfected with activated oncogenes 
to derive altered cells that mimic premalignant lesions when tested in immune deficient 
mice [75]. Smith and colleagues have used murine models to investigate DNA division in 
label-retaining epithelial cells in the mouse mammary gland through transgenic 
mammary implants [76-78]. Animal models frequently provide definitive tests of the 
importance of specific molecules and processes; however, there can be discrepancies 
between conclusions due to the distinct differences between human and animal tissues 
and the chemicals that could interfere with the function of specific proteins [64]. 
Although animal models are able to provide us with relevant biological interactions and 
help in the understanding of developmental biology, they are costly and complex with 
problems of unpredictable characteristics and ethical approval, thus other physiological 
3D model systems are more desirable [65]. 
Normal Mammary Epithelial and Tumor Models 
Normal human and murine mammary epithelial cell culture models have been 
established in order to uncover the key components of initiation and maintenance of cell 
differentiation, which include both the cell and the surrounding microenvironment [69]. 
While these models have investigated the correlation between cell shape and growth and 
differentiation [45, 46, 66], the role the ECM plays to influence cell phenotype [67, 69, 
79, 80], and the epithelial-stromal interactions [13, 25, 81], natural materials (e.g. 
collagen, rBM) are used in these culture models to maintain a morphology reminiscent of 
the in vivo conditions [69]. The natural materials used in these culture conditions provide 





limited by the components present in the model system; thus, interpretations of data from 
these systems need to be weighed against the limitations of the particular system [74]. 
Cancer models have significantly enhanced our understanding of carcinoma 
biology in four areas: the formation and maintenance of a hollow glandular lumen and its 
disruption by cancer genes, the regulation of apicobasal polarity in normal and cancerous 
epithelium, the discovery that cell-cell and cell-matrix adhesion pathways can interfere 
with the phenotypic expression of the tumorigenic state, and the emerging importance for 
tensional force in driving 3D tissue architecture and homeostasis [74]. While these four 
areas are of great importance in understanding tumor formation and cancer progression, 
others have used 3D models to evaluate the cytotoxicity and toxicology of cancer drugs 
[82-84]. 
Overall, current 2D and 3D models have allowed insight into the development 
and function of normal mammary epithelial tissue, tumor formation and cancer 
progression, as well as evaluation of effective therapeutic agents in cancer treatment; 
however, there are limitations as to what cellular and matrix components are used, what 
these models can accomplish, and how well they represent the true in vivo breast 
conditions. 
Adipose Tissue Models 
Engineered adipose tissue, composed of the patient’s own cells, a suitable 
scaffold, and appropriate growth factors, was initially developed for use in breast and soft 
tissue reconstruction after tumor resection [85-87]. Preadipocytes and mesenchymal stem 





87], and porous polymers [56-58, 88] in order to produce a defined volume of adipose 
tissue for implantation into a defect site. While these tissue engineering strategies have 
been used for reconstruction, they are inherently useful in breast tissue model systems as 
the breast, in its entirety, is composed of the epithelial parenchyma surrounded by 
intrastitial and interstitial ECM, all embedded in the mammary fat pad. Numerous 
natural, synthetic, and hybrid materials have been used to act as adipose surrogates; they 
have predominantly been used to replace adipose volume and not function [85]. To date, 
epithelial culture systems have been used to recreate the cardinal features of glandular 
epithelium in vivo and represent a valuable tool for modeling breast cancer initiation and 
progression in a structurally appropriate context [74], but have not been used to 
determine how adipose tissue influences mammary gland structure and development. 
Improvement upon the current model systems is needed for translational results and 
further understanding. 
Tissue Test Systems 
A three-dimensional model system that is used in applications where a whole 
tissue is represented can also be referred to as a tissue test system. Tissue test systems are 
developed to represent the in vivo conditions, provide a tunable system to investigate 
certain aspects of the environment, and also allow precise data collection. In any 3D 
model system, the specific cellular and matrix microenvironment provided to the cells 
can substantially influence the experimental outcome [64]; thus, the model/tissue test 
system should be designed to provide the necessary cellular and micro-environmental 





cell type(s), scaffold material or components, and micro-environmental cues, such as 
hormones, growth factors, etc., all play a considerable role in the development of the 
overall tissue test system. Current 3D model systems have limitations as to how they 
perform and the data that can be obtained, therefore development of a tunable system 
would be helpful to understand all aspects of the tissue and its function in vivo. 
Normal Breast Tissue and Breast Cancer Models 
Studying normal breast tissue biology, architecture, and development to 
understand how human breast cells grow, interact, and undergo programmed cell death 
began with 2D culture of cells [45, 46, 66-68, 89, 90] coupled with the development of 
cell lines to be used for research purposes. Two-dimensional models have allowed a 
better understanding of the effect of the surrounding environment on cell growth [66, 67], 
proliferation, interaction [90], differentiation [45, 46, 67], and apoptosis. Further 
investigation of human breast development, the pathological progression of breast cancer, 
and therapeutic drug evaluation continued to be answered through use of 2D models such 
as the NCI60 cell line assay [41, 70, 71]. Although these models were able to identify key 
biological development processes and interactions of mammary epithelial cells, the 2D 
models do not represent the complete in vivo conditions of the normal and cancerous 
breast. The mammary gland is a complex tissue; thus, in order to evaluate the complex 
phenotypic alterations of the mammary epithelial cells and the surrounding 
microenvironment [91], 3D models have been developed. The advent of 3D cell culture 
models has allowed investigators to make significant progress toward characterizing the 





The function of an organ relies upon the organ’s constituent cell types and overall 
organization; i.e., the structure of a tissue or organ is critical for its function [92]. In 
developing 3D models and tissue test systems, achieving and maintaining the remarkable 
level of tissue organization, mammary epithelial cells (MECs) and their surrounding 
ECM components must integrate their structure in a highly concentrated fashion [93]. 
Tissue engineering, i.e. the construction of tissues using cells and biomaterial “scaffolds” 
or “matrices” as foundational building blocks, has been of interest for many years for 
mammary reconstruction following mastectomy or lumpectomy, and has been 
investigated more recently for use in building 3D mammary tissue models [6]. Many 
different natural and synthetic materials, cell types (primary cells or cell lines), and 
microenvironments have been used in order to engineer normal breast tissue and breast 
tumor tissue. Many of the tailored models that have been use to investigate normal and 
malignant breast tissues are outlined further in order to describe the specific niches 
researchers have thoroughly explored in order to fully understand the biological 
principles of the mammary gland tissue and the breast environment.  
Ductal Structure Formation, Terminal End Bud Motility, and Epithelial Cell Polarity  
Ductal structure formation, terminal end bud motility, and epithelial cell polarity 
are all dependent on the microenvironment and interactions of the epithelial cells with 
each other and the basement membrane. A great deal of breast biology and breast cancer 
research on ductal structure formation has included mammary epithelial cells or breast 
cancer cells embedded in natural materials such as collagen Type I, reconstituted 





represent the naturally-occurring ECM of the breast [79-81, 94]. Dhimolea and 
colleagues found that flexible Type I collagen matrices supported polarized acini and 
branching ducts when human breast epithelial (MCF10A) cells and human mammary 
fibroblasts obtained from reduction mammoplasties (RMF) cells were suspended in the 
gels in co-culture [79]. Krause and colleagues co-cultured MCF10A and RMF cells 
embedded in a Type I collagen gel, which resulted in the development of branched ducts, 
but when rBM was added to the collagen in a 1:1 ratio, branching ducts and alveoli were 
produced [81]. Dréau and coworkers found that the behavior of 3D cultures of normal 
murine mammary gland (NMuMG) cells, cultured either alone or in combination with 
mouse mesenchymal stem cells (D1), were dependent on the “matrix” or surrounding 
biomaterial environment consisting of agarose, collagen, or Matrigel™ alone or in 
combination [95]. The number of acinar structures was significantly higher in cultures 
grown in combination matrices of agarose with Matrigel™ or collagen I when compared 
to cultures grown in Matrigel™ or collagen I alone. No tubular structures were formed 
when agarose was included in the matrix, regardless of the combination. These works 
highlight the process of ductal formation, demonstrating how epithelial cells react in 
different gel environments, highlighting the fact that the surrounding microenvironment 
plays a particular role in normal ductal formation and overall regulation of ductal 
branching and lobular formation in the breast. The downfall of these studies is that the 
researchers do not include all the components found in the normal and cancerous breast 
environments. If researchers are to investigate the development of the normal breast, they 





ductal tree. Without the adipose and stromal cell components and their signaling factors 
and influence within the model system, the results from these tissue models do not fully 
represent the native tissue. Model systems are just beginning to use all of these 
components in one system, Wang and colleagues cultured human breast epithelial cells in 
a tri-culture with stromal and adipose cells in a silk scaffold in which the cells displayed 
more differentiated morphological phenotype and functional activity compared to mono- 
or co-culture of the cells. [96] This study in fact demonstrates how current model systems 
are deficient and what they should strive for in the future.    
The TEB, at the tip of the ductal structure in the normal breast, initiates invasion 
into the surrounding fat pad of the breast [97]. Proliferation of TEB cells results in ductal 
elongation, while clefting results in bifurcation or branching of the ducts [97]. Ductal 
formation and TEB motility is guided by changes in the surrounding ECM components, 
specifically the fat pad and fibroblasts surrounding the epithelial cells [13]. The TEBs 
include a cell population with high rates of mitosis which are known to include endocrine 
and local growth-regulatory signals, stromal-epithelial interactions, ECM remodeling, 
and dynamic adhesions within the end buds that maintain the bilayer structure [22]. As 
TEBs advance through into the fat pad, remodeling of the surrounding ECM is necessary 
for the ductal structure to advance, branch, and expand. Remodeling of the ECM usually 
occurs through systematic crosstalk between the adipose cells, fibroblasts, and cap cells 
of the TEB and includes signaling proteins such as BMP, Wnt, and EGF [97]. 
Metalloproteinases (MMPs) the principal matrix-degrading enzymes, are regulated by 





Luminal epithelial cells are polarized glandular cells with specialized apical and 
basolateral membrane domains [98]. The permanent loss of polarity in tumors disrupts 
tissue structure, compromises the segregation of signaling effectors, and exacerbates the 
increased cell proliferation that is induced by other oncogenic signals [19]. In normal 
breast development, luminal epithelial cells orient themselves through cues from myo-
epithelial cells and the surrounding BM, although the exact signaling mechanisms are not 
fully understood. Experiments have focused on polarity through the formation of the 
mammary ductal structure and also how a lack of polarity and BM deposition is 
characteristic of tumor cells [98]. Gudjonsson and colleagues used breast luminal 
epithelial and myo-epithelial cells derived from reduction mammoplasty biopsies and 
residual tissue from breast carcinoma mastectomy specimens to investigate the 
differences in normal and myo-epithelial cells and their interactions with luminal 
epithelial cells to recapitulate polarity [21]. Double-layered breast acini formed when 
normal luminal and myo-epithelial cells were cultured together, but when normal luminal 
and cancerous myo-epithelial cells were cultured together only some acini formed, due to 
a lack of laminin-1 production from the cancerous myo-epithelial cells, demonstrating the 
importance of laminin-1 production and the role of the myo-epithelial cells in 
maintenance of polarity in normal breast and how myo-epithelial cells may function as 
structural tumor suppressors [21]. In contrast, Liu and colleagues investigated the 
potential connection of cellular proliferation and polarity to tumor expansion and 
invasion; these researchers demonstrated that although cell proliferation and polarity 





phenotype [19]. These studies highlight the importance of polarity in the normal breast as 
well as in tumor initiation, progression, and metastasis. The models used here to 
investigate polarity and the influence it has in the cancerous breast are lacking the cellular 
and structural components that would be seen in the cancerous environment. Polarity 
models should not only include the normal and cancerous epithelial cells, but fibroblasts, 
macrophages, inflammatory cells, and endothelial cells. The tumor microenvironment is a 
heterogeneous environment that is most notably characterized by an increase in fibroblast 
and myo-fibroblast activity, increased angiogenesis, increased infiltration of 
inflammatory cells and remodeling of the extracellular matrix adjacent to the cancerous 
cell. [28] Without the influence and inclusion of these cell types and structural 
components within the current models, we will not be able to completely understand how 
polarity affects tumor initiation, progression, and metastasis. 
Overall, understanding the developmental biology of ductal structure formation, 
terminal end bud motility, and polarity within the normal breast environment is crucial to 
advancing technology for breast cancer detection, prevention, and cures. 
Hormones, growth factors and signaling molecules 
The development of the mammary ductal structures involves a complex interplay 
between epithelium and mesenchyme; the branching of the mammary ducts is dependent 
on circulating hormones for stimulation and synchronization with reproductive events, 
but is also influenced by local factors to provide signals that influence glandular growth, 
differentiation, and morphogenesis [99]. Extracellular signals are transmitted across the 





changes in these receptors, triggered by ligand binding, in turn cause rearrangement of 
the cytoskeletal network and intracellular cascade of signal transduction, leading to 
changes in gene expression, and therefore the growth and differentiation state of the cells 
[69]. 
During normal breast development, estrogen and progesterone are required for 
proliferation and morphogenesis of the normal mammary gland; estrogen drives ductal 
development during puberty, whereas estrogen plus progesterone mediate the 
proliferative and morphological changes of ductal side-branching and alveologenesis that 
occur at sexual maturity and during pregnancy [100]. Both epithelial and stromal cells 
express the estrogen receptor (ER)-α [92], which is a crucial regulator of branching in the 
virgin gland [101]. The hormone progesterone, in combination with the prolactin receptor 
(PRL), promotes differentiation of the alveoli, which are the structures that synthesize 
and secrete milk during lactation during pregnancy [101]. In vivo studies by Smith and 
coworkers examined two populations of slowly dividing (label-retaining) cells, ER-α-
positive and progesterone receptor (PR)-positive, which were equally represented among 
the body cells of the TEBs and within the epithelial of the subtending ducts of the FVB/N 
mice [77]. In the normal mammary glands of both mice and women, ER-α-positive cells 
are not normally proliferative, but this association is lost in breast cancer [100, 101], thus 
providing a breast cancer indicator for which one can test. Additionally, prolactin was 
examined by Gill and colleagues using immunohistological processes to compare normal, 
benign, and malignant breast tissues, where PRL was expressed at different sites within 





breast carcinomas, and was correlated with strong staining for ER-α-positive but not 
other prognostic factors [102]. These studies have all looked at the influence of hormones 
within the glandular structure; however, most of these studies are conducted in animal 
models or through histological evaluation of biopsied tissue. Animal models, while 
useful, are not the best representation for extrapolation to human condition. Rodents 
typically possess very little subcutaneous adipose tissue [51] and the mammary glands 
are not structurally the same; in many rodents and other mammals the glands are 
relatively thin and flat. [15] In summary, to advance the understanding of hormonal 
influence and interactions within the normal and cancerous breast environments, use of 
animal models that are better representative of the human condition and development of 
in vitro models is crucial. 
While estrogen and progesterone and their receptors are necessary in normal 
mammary gland development, there are growth factors that are also important. 
Hepatocyte growth factor (HGF) is a mesenchyme-derived growth factor that is 
synthesized in the stroma in vivo and stimulates the proliferation, motility, and 
morphogenesis of nearby epithelium [103]. Haslam and colleagues investigated cell 
proliferation of luminal and myo-epithelial cells of the mammary gland in organoid 
culture; cell proliferation did not increase with progestin (R5020) or 17β-estradiol (E2) 
alone or R5020+E2, but did increase when HGF was added to E2 and further increased in 
combination with R5020 forming tubules off the organoids [103]. There is also evidence 
of bidirectional crosstalk between epidermal growth factor receptor (EGFR) and β1-





mammary epithelial cells (HMT-3522) and human mammary tumor cells (T4-2) in 3D 
rBM in order to evaluate the bidirectional cross-modulation of β1-integrin and EGFR 
signaling, which does not occur in 2D culture [94]. The group found that regulation of 
EGFR (as well as β1-integrin) is linked to tissue morphogenesis, that EGFR and β1-
integrin pathways are coupled, and that as long as the pathways are not altered or deleted, 
aberrant behavior can be corrected, thus restoring normal function to tumor cells in a 3D 
BM. These studies demonstrate the importance that growth hormones and their receptors 
play in the overall development of the normal mammary gland as well as tumor initiation 
and progression. 
Some of the most researched signaling molecules in the breast are the 
transforming growth factor β (TGFβ) family, composed of three isoforms (1, 2, and 3), 
which have been identified as multifunctional cytokines with pivotal roles in several 
cellular functions including cell growth, differentiation, extracellular matrix production 
and degradation, motility, and regulation of the immune system [24, 104]. Osin and 
colleagues used histological staining to determine where TGFβ was found in fetal and 
infant breasts; they found that TGFβ was localized to the ECM, suggesting that TGFβ 
plays an important role in inhibiting epithelial proliferation at specific sites and thereby 
influencing morphogenesis [105]. TGFβ inhibits branching morphogenesis during 
puberty, blocks formation of alveoli and secretion of milk during pregnancy, and 
promotes apoptosis during involution [92]. Beyond TGFβ and its effects in normal and 
stromal microenvironments, there are many other growth factors, signaling molecules and 





While these studies are great beginning points and have given us insight into the 
crosstalk and signaling that occurs in the normal and tumor microenvironment, there is 
still much technical insight to be gained. Further development is needed for model 
systems to include the stromal components, i.e. fibroblasts, adipocytes, and other cell 
types found within the microenvironment being studied in order for researchers to better 
understand the underlying mechanisms influenced by hormones, growth factors, and 
other signaling proteins. 
Stroma 
The stroma is composed of multiple cell types that co-exist within the ECM 
network, where the cellular components evolve with the developmental stages of the 
mammary gland [13, 24]. Therefore, it is expected that the variations seen in epithelial-
stromal interactions and ratios that occur during the different stages of breast 
development will influence the components of cellular microenvironment (growth 
factors, hormones, and ECM) and, in turn, influence gene expression that may account 
for the susceptibility or risk to develop breast cancer [99, 106]. While research has 
focused on epithelial-stroma interactions and how they influence the proliferation, the 
differentiation, and, at times, the quiescence of the epithelial cells and their progenitors, 
there is still information about the cellular interactions and their influence on cellular 
behavior in the normal breast and breast cancer environment that is unknown.  
In vitro model systems have been developed, through the use of tissue 
engineering methods [107], in order to better understand the development and structure 





influences breast cancer initiation and progression. While normal formation of the 
mammary gland depends on the coordination of physical and biochemical signals from 
the normal microenvironment (defined by neighboring cells, surrounding ECM, and local 
soluble factors) [93], tumor initiation and progression are marked by an imbalance in the 
microenvironment. In normal mammary tissue, where multiple cell types co-exist, 
homeostasis and involution are driven by programmed cell death (PCD, or apoptosis 
regulation) through cell-cell and cell-ECM adhesion as well as the 3D tissue architecture 
[108].  
Stromal interactions 
Normal growth, function, and homeostasis of breast epithelial cells depend on 
intricate interactions between the numerous surrounding stromal cells within the 
mammary gland [109]. These cells secrete multiple cellular products, such as growth 
factors and ECM components, which influence normal epithelial cell behavior, while 
alterations in regular communication between these cells, i.e. an abnormal stromal 
environment, can lead to the progression or expansion of malignant growth [73, 109].  
Within the stroma, fibroblasts and the molecular signals they produce seem to 
play a critical role in normal and malignant epithelial cell behavior. Fleming and 
colleagues demonstrated that fibroblasts in the surrounding intralobular and interlobular 
do not show genetic differences, but they do influence the progression of malignant 
growth [109]; therefore, these researchers suggested that co-culturing fibroblasts with 
cancer cells would be necessary to examine tumor progression and metastasis. Recently, 





order to determine how cancer-stromal interactions influenced gene expression and found 
that the molecular crosstalk between neoplastic and the surrounding tissue induced 
several stromal changes, including neoangiogenesis and immune/inflammatory reaction, 
as well as new ECM formation and the activation of fibroblast-like cells (i.e. 
desmoplasia) [110]. Although fibroblasts seem to be important to stromal interactions 
with mammary epithelial cells, ECM components also regulate epithelial cell behavior. 
Cell adhesion plays an important role in a variety of basic biological processes, 
including guiding cells into their appropriate locations in the body, providing cell 
anchorage, and controlling cell proliferation, differentiation, and apoptosis [111]. The 
identification of cellular transmembrane receptors for specific sequences present on ECM 
molecules established that ECM molecules affect cellular behavior. These molecules 
include integrins, cell-surface proteoglycans, and other receptors [24]. Integrins are a 
family of heterodimeric transmembrane proteins composed of α and β subunits that 
contribute to the ligand specificity and contain potential binding sites for ligands [111]. 
These ligands specifically bind to protein sequences, for example, the RGD sequence 
found in many of the ECM components [24, 111], and regulate cell behavior through 
signaling pathways. There is also evidence that in mammary epithelial cell cultures, ECM 
must suppress growth before signals for differentiation can be received [24]. Bissell and 
colleagues have conducted many studies to determine how these ligands and cell 
adhesion receptors influence the luminal epithelial cell polarity and ductal formation and 





ECM Architecture, Stiffness, and Mechanical Forces 
The stroma and cellular architecture, stromal components, ECM stiffness, and 
mechanical forces regulate the formation and branching of the mammary gland 
parenchyma. Each of these influences epithelial and stromal cell phenotypes, thus 
impacting the development, regulation, and function of the mammary gland and 
surrounding stroma as well as tumor formation and metastasis. 
The ECM architecture and epithelial cytoskeletal architecture are imperative in 
normal cellular function, while loss of ECM architecture is inherent in involution of the 
mammary gland and impacts cell migration. All cells contain a cytoskeleton which is 
important in orchestrating cellular events such as cell motility, protein 
trafficking/secretion, and mitosis [112]; this cytoskeleton is composed of actin 
microfilaments, microtubules, and intermediate filaments (IFs; see Figure 1.3), which 
determine the mechanical properties of adherent cells [113]. Researchers have 
investigated how the intermediate filaments, specifically vimentin in fibroblasts, 
influence cell stiffness and migration [112-115]. While cellular stiffness and cell-cell 
junctions (e.g. E-cadherin in adherens junctions, see Figure 1.3 [97]) increase the 
stiffness of a given tissue, the ECM architecture of the BM and the supporting connective 
tissue has been determined to influence cellular behavior as well. The ECM BM is 
integral to the polarity of luminal epithelial cells [18] and maintaining tissue function of 
the mammary gland [108], while collagen stiffness regulates cellular contraction, matrix 






Figure 1.3 Scheme of dynamic reciprocity between cells and their microenvironment. Cell-
cell and cell-ECM interactions cause a cascade of biochemical and mechanical signaling to 
the nucleus, which in turn affects the cellular micro-architecture and gene expression 





Stiffness of the mammary gland parenchyma and surrounding stroma plays an 
integral role in cell migration and gene expression. Hadjipanayi and colleagues 
investigated the migration of cells over a collagen matrix with a graded directional 
stiffness, where it was determined that cells migrate to stiffer surfaces and that the speed 
of migration increases on softer matrices [116]. Karamichos and colleagues used collagen 
matrix stiffness to assess the gene expression of matrix metalloproteinases (MMPs), 
which are produced in order to degrade ECM proteins for cell migration, and found that 
with an increase in stiffness there was an increase in MMP-2 production [117]. Research 
conducted by Hadjipanayi and Karamichos involves the use of dermal fibroblasts in 
collagen matrices and while it does not directly include breast cells, it is useful in 
understanding how cells migrate. Improvements in these methods might include starting 
with the replacement of dermal fibroblasts with epithelial cells and stromal cells within 
the collagen matrix, but then progressing to use of a system that incorporates the entire 
cancerous environment to better understand not only how tumors attract different cells, 
but also how metastatic cancer cells migrate to other tissues. Research of normal and 
tumor tissue requires the development of 3D models that reflect the tissue stiffness and 
components in order to best represent the native tissue. Samani and colleagues have used 
mechanical testing of normal breast tissue and breast tumor tissues in order to determine 
the stiffnesses necessary for development of future 3D models [119]. While these 
researchers have made progress toward understanding the processes involved in cell 





more to investigate and understand with the use of 3D model systems that can be tailored 
to a specific research question. 
When modeling epithelial-stromal interactions, it is important to recognize that 
many studies exclusively employ epithelial cells and lack any stromal components [91]. 
While these studies have been able to give researchers insight into cellular behavior, the 
mammary stroma comprises over 80% of the cellular population of the in vivo gland, thus 
studies should use co-culture of epithelial cells and their stromal counterparts to 
investigate the relationships and subsequent behaviors [91]. 
Tumor Microenvironment 
Tumors persistently shape their microenvironment, thereby establishing an 
abnormal ecosystem [120]. The tumor microenvironment is represented by an increase in 
fibroblast and myofibroblast activity, an increase in angiogenesis, an infiltration of 
inflammatory cells, and ECM remodeling adjacent to the cancerous cells [28]. While all 
of these components contribute to tumor progression, macrophages, recruited to the 
tumor by various signals, begin to release chemotactic factors that in turn recruit 
monocytes to the area that mature into tumor-associated macrophages (TAMs) which in 
turn promote neoplasia and angiogenesis [121]. In support of this theory, Robinson and 
colleagues found that the macrophage density increased with the grade of the tumor (in 
situ to invasive), that vessel density was higher in in situ and invasive tumors, and that 
there was a lack of epithelial cells in any proximity to either tumor cells or macrophages 
[1]. However, their results were not conclusive; thus, better understanding of the 





achieved through heterogeneous model systems. Further research studying the tumor 
microenvironment by Rodrigues-Lisoni and colleagues focused on gene expression 
influenced by the cancer-stroma interactions using conditioned medium (HCM – Hep2 
Conditioned Medium, FCM – Fibroblast Conditioned Medium) from Hep2 cancer cells 
and fibroblasts. These researchers measured the gene expression and its influence on 
angiogenesis, the immune/inflammatory response, ECM formation, and fibroblast 
activation in culture [110]. They found that FCM inhibited Hep2 cell line proliferation 
and induced apoptosis, suggesting that factors secreted by fibroblasts include proteins 
that interfere in cell growth and death of neoplastic cells, whereas fibroblasts treated with 
HCM down-regulated genes corresponding to biological processes such as cell 
proliferation, transport, transcription and translation, apoptosis, and protein and RNA 
metabolism [110]. While this study shed light into gene expression of tumor cells and the 
influence of soluble paracrine factors produced in vitro by stromal cells, the study lacked 
the 3D nature of the body, as all culture was completed in well plates. Further studies 
should be conducted in 3D to better understand gene expression and how it influences the 
tumor microenvironment and progression of a tumor. 
The tumor microenvironment is driven by the soluble factors and crosstalk 
occurring between the multiple cell types present within and surrounding a tumor. While 
studies have begun to address the individual interactions that occur between tumor cells 
and the surrounding vasculature cells, inflammatory and immune cells, fibroblasts, and 
macrophages, they have yet to piece this heterogeneous microenvironment together. 





systems could be developed to further enhance the understanding of the tumor 
microenvironment, especially for each pathological state, by seeding relative cell 
densities of the representative cell populations within the model systems. By 
incorporating the different types of cells beyond epithelial cells, researchers create a 
microenvironment more representative of the pathological state. 
Cytotoxicity and Toxicology 
Cytotoxicity and toxicology models started in 2D using assays to determine how 
cancerous cells reacted to drug therapies. The National Cancer Institute developed the 
NCI60 cell line, which includes 60 different human tumor strains, for cancer cell 
microarray testing to evaluate cellular behavior including early clinical trials of drugs 
[72] and gene expression [71]. With the advent of 3D models and the better 
representation of the normal tissue environment in 3D compared to 2D cell culture, 
current toxicology models use tumor cells grown in natural and synthetic materials. 
Research groups have used polymeric substrates, such as electrospun polycaprolactone, 
poly(ethylene glycol) diacrylate hydrogels, and polylactide-co-polyglycolide 
microspheres or porous disks, to create 3D engineered models of adipose tissue to assess 
the cytotoxicity of breast cancer drugs [47, 52, 56, 83, 87, 88]. Horning and colleagues 
used polylactide microspheres seeded with MCF-7 cells in order to evaluate the efficacy 
of cancer drugs in 3D and 2D in vitro models, determining that drug efficacy is 
significantly lower in 3D compared to 2D culture and suggesting that the role of the 
natural 3D cellular architecture affects drug uptake by the cells and lowers the 





Although this study demonstrated why a third dimension is necessary when evaluating 
toxicity of cancer drugs, their study was not comprehensive and representative of the 
natural environment, i.e. incorporating all the cellular components present in the body. 
Other limitations of this study were that it not only used different substrates in their 2D 
and 3D comparison, but they used a set cell concentration within the culture 
environments instead of seeding for confluency (i.e. seeding based on surface area), 
which could influence results as cells could be confluent in 2D culture, but may not be in 
3D culture inhibiting a true comparison of results. Similarly, Dhiman and colleagues 
evaluated the cytotoxicity of tamoxifen on 3D cultured MCF-7 cells on a chitosan matrix; 
the 3D culture provided a better understanding of the carbohydrate metabolism, cytotoxic 
effect of tamoxifen, and the kinetics and uptake of cathepsin D in breast cancer cells [82]. 
Limitations of this study by Dhiman were the use of cell lines instead of primary cells, 
the fact that different substrates were used in 2D compared to 3D and that material 
characterization was not conducted to determine if the substrate could influence results. 
Such 3D cancer models can be used to evaluate new anticancer drugs and to provide 
better understanding of the signaling factors that influence cancer cell growth, but 3D 
models that address the above limitations need to be developed before in vitro 
cytotoxicity and toxicology models will be comparative to human response in vivo. 
Adipose Tissue Engineering 
The majority of mammary gland and breast cancer research focuses on epithelial 
cells and the surrounding ECM interactions, further, adipose tissue and its influence in 





investigated. Tissue engineering of adipose tissue using natural or synthetic scaffold 
paired with stem cells or preadipocytes has been the focus of adipose research for soft 
tissue defects of late [56, 122-124]. 
Stem cells or preadipocytes have previously been used to produce mature adipose 
tissue for applications in replacing soft tissue due to trauma, diseases, or congenital 
abnormalities [87, 124, 125]. For example, Halbieb and colleagues seeded preadipocytes 
on a hyaluronic acid-based scaffold and found that hyaluronic acid-based scaffolds 
appear to be suitable three-dimensional carriers for culture and in vitro differentiation of 
preadipocytes [56], however, material characterization was not completed on the scaffold 
material to determine the degradation rate, stiffness, or other material properties which 
influence how cells react within the 3D system. Similarly, Patrick and colleagues seeded 
PLG polymer disks with preadipocytes to demonstrate the potential of using 
preadipocytes as a cell source in cell-seeded polymer scaffolds for tissue engineering 
[52]. This study was further developed to investigate the long-term feasibility of these 
cell-seeded scaffolds for clinically translatable, tissue engineered constructs for 
reconstructive, correctional, and cosmetic indications by implanting the scaffolds 
subcutaneously on the back of rats [51]. Although these preliminary studies were able to 
prove that preadipocytes would proliferate and mature throughout the polymer scaffold, 
in the long-term study the lack of vascularization and rat microenvironment around the 
implants may have contributed to a decrease in adipose tissue after 2 months in vivo. 
Reinforcing the limitations of rodent models in bioengineering research, where rodent 





constructs decreased in the amount of adipose tissue present after 2 months. Beyond 
designing engineered adipose tissue for soft tissue defects and reconstruction application, 
the ability to understand adipose differentiation is important. Kang and colleagues used 
an adipose tissue model of preadipocytes seeded on fibrous polyethylene terephthalate 
(PET) polymer matrices to understand the mechanisms behind adipose tissue 
differentiation [58]. The researchers determined that the PET nanoscale fibers provided a 
microenvironment for cell differentiation and spatial organization, thus mimicking the 
morphology of ECM in adipose tissue. Preadipocytes have not been the only cell type 
used in adipose tissue engineering; many studies have used mesenchymal or embryonic 
stem cells in adipose tissue engineering applications [47, 48, 57, 87, 88]. Recently, Kang 
and colleagues used murine embryonic stem cells seeded on an electrospun 
polycaprolactone (PCL) matrix using an adipogenic cocktail to produce functional fat 
cells [88]. The 3D geometry of the electrospun matrix provides environmental cues for 
adipogenesis and 3D structural features and functionality that cannot be obtained in 2D 
cell culture. Although all of these studies have focused on developing methods in which 
to engineer adipose tissue for soft tissue defects and breast reconstruction and they do not 
address the fact that the microenvironment of adipose tissue is highly vascularized and 
contains much more than just adipose cells, they are still useful in helping to better 
understand the adipose microenvironment and challenges of developing a comprehensive 
model system for the normal breast and breast cancer. Some of the limitations of the 
previously mentioned studies that need to be addressed are that the material needs to 





upholding the mechanical properties of normal adipose tissue through material 
characterization. The substrates used also have to allow for spatial organization of the 
preadipocytes in order to fully differentiate into mature adipocytes. Hopefully, further 
studies will expand on the knowledge gained from these adipose tissue engineering 
studies in order to build thorough tissue models for use in normal breast and breast cancer 
research in the future. 
Whereas synthetic polymer substrates may fully represent the tissue ECM, the 3D 
geometry provides environmental cues for adipogenesis that cannot be obtained in 2D 
(monolayer) culture [88]. The substrates provide the necessary mechanical stability, 
attachment capability, and biocompatibility to produce function-specific tissue [83]. 
Epithelial cells are anchorage-dependent cells that require a substrate to ensure proper 
cell morphology and functionality. In fact, while synthetic polymeric materials with the 
appropriate binding sites may be suitable for adipocytes, natural materials generally 
facilitate polarity in epithelial cell cultures. However, use of synthetic polymeric matrices 
seeded with preadipocytes, or stem cells, combined with epithelial cells and fibroblasts 
(which would not normally be incorporated for tissue reconstruction following breast 
cancer), and embedded in a collagen-rBM gel has the potential to produce engineered 3D 
models that better represent the architecture and microenvironment of the breast [6]. 
Overall, the unique mammary gland microenvironment influences mammary 
tissue homeostasis through cues from hormones, soluble factors, stroma, and physical 
stress and strain [74]. Tissue engineering and model systems can help better represent the 





microenvironment and ECM are key components of 3D in vitro mammary systems that 
can be tailored to study normal epithelial cell-stromal interactions, gland development, 
and breast cancer initiation, progression, and metastasis 
Epilogue 
Approximately 1 in 8 women in the United States will be diagnosed with breast 
cancer at some point in their lives [1]. Breast cancer begins when normal mammary 
epithelial cells begin to grow and divide out of control, forming a cell mass which then 
invades surrounding tissue and eventually, if not caught and diagnosed, leads to 
metastasis. In an effort to understand normal mammary gland development and function 
and how breast cancer begins, much research has been conducted to understand how cells 
become cancerous in the mammary gland, how they propagate, and how they eventually 
metastasize throughout the body. The complexity of the tumor microenvironment is 
immense and much information is still necessary for better understanding how the 
relationship between stroma and carcinoma cells can be used for diagnostic and 
prognostic evaluation and a target for therapy [110]. While this research has helped us 
understand some of the underlying mechanisms associated with normal mammary gland 
function and breast cancer, there is still much we do not understand; the diagram below 
(Figure 1.4) details the pros and cons of the current model systems and the needs to be 







Figure 1.4 Types of models available for normal breast and cancer research. Pros and cons 
are listed for each model, also included are a list of suggested 3D model improvements. 
Normal breast and breast cancer models have been developed to investigate many 
aspects of form, function, and interaction within the breast microenvironment, beginning 
with 2D and animal models and progressing to 3D models. Two-dimensional cell culture 
models are easy to generate and assess, but these models lack the realistic third 
dimension of the body. While these models are able to provide a better understanding of 
the normal interactions and development of the mammary gland, as well as tumor 
formation, progression, and microenvironment, they are not able to mimic the cellular 
conditions of the human body and do not normally include all the components (i.e. 





representative of the normal breast or tumor environment. The ultimate goal is to develop 
a culture system in which cells respond to various extracellular signals in a manner that is 
physiologically relevant; the first step toward achieving this goal is to allow the cells to 
maintain a morphology reminiscent of their counterparts in vivo [69]. Two-dimensional 
models, while appropriate for pilot studies and initial investigative research, do not mimic 
the 3D tissue microenvironment and provide different results compared to animal and 3D 
models. 
Animal models are used in research to provide an environment which is spatially 
and biochemically more relevant to the human biology than the 2D in vitro models. In 
cancer research, animal models have been and are used to investigate cell characteristics, 
cellular components comprising the tumor microenvironment, and tumor formation. 
While they provide insights and data that cannot be reproduced in 2D model systems, 
they still have inherent limitations. For example, when tumors are grown in immune 
deficient or compromised mice, there is an accelerated development of the mammary 
gland structure which correlates with the development of the human mammary gland, but 
the glandular components, development of the ductal structure, and percentage of fat in 
the mammary pads is not representative of the human environment. Also, the absence of 
a normal immune system in those mice prevents any analysis of the key role of the 
immune system in both mammary gland physiology and mammary tumor progression. 
Also, rodents have a much smaller percentage of fat compared to humans, thus the 
influences that may be seen from the mammary fat pad of a human cannot be fully 





hormones, and other factors than humans. These may influence or conflict with the 
signaling factors and biomaterials that are being studied in the experiments. Finally, 
conduction of in vivo animal studies can be costly and limit time points investigated. 
Beyond that, the animal model variabilities (e.g., genetic, experimental, methodological) 
can also influence data obtained highlighting the need for 3D alternative models. In 
contrast, 3D test systems can be precisely replicated for experiments,  
While each of the above models is useful to better understand normal breast and 
cancer development, each has a specific niche and limitations. Two-dimensional models 
were first developed as rudimentary systems in which to investigate cell response. While 
these models have been extensively used to date, one must be aware of the drawbacks. 
Animal models, although used less frequently, have provided perspective and expanded 
understanding of the mechanisms involved in breast and cancer development. Initial 
experimentation will continue in 2D and animal models as proof of concept, to test 
biocompatibility, or to benchmark against but 3D models must be developed to add 
crucial missing information regarding normal and cancerous breast tissue.  
In the past two decades, researchers have realized the importance of 3D model 
systems especially, for cellular function and signaling. Even though the use of a 3D 
model inherently adds complexity to the culture system, a 3D system more closely 
represents the tissue conditions. Currently, multiple 3D models are available including 
using scaffold materials, either natural or synthetic, in or on which the cells are grown. 
There is a range of materials that have chemical and structural properties that can be 





conducted in rBM, laminin, or collagen in order to mimic the ECM present in the breast. 
Subsequently, many adipose tissue models have used synthetic materials (i.e., 
polylactide, PLG, PCL) in different forms to provide structural support for the stem cells 
or preadipocytes. Cell type and selection is another key parameter to consider in 3D 
models; while cell lines are great to study initially to determine how the cells react within 
the modeled environment, these cells typically are transformed and have lost many of 
their phenotypic characteristics, thus the 3D models using cell lines may only partially 
mimic the tissue of interest. These multiple parameters of a 3D model system should be 
critically considered when investigating biological responses within 3D models of the 
mammary gland environment and of breast cancer progression. 
Beyond epithelial cell and scaffold selection, 3D models currently are missing 
other molecular, cellular, and structural components. Most 3D models still use a single 
cell population and very few include multiple cell types. In order to encompass a more 
relevant range of cellular components of the mammary gland or tumor, the 3D model 
system must include epithelial and myo-epithelial cells, fibroblasts, adipose cells, 
inflammatory cells, and vascular cells. All of these cells add to the overall 
microenvironment of the breast, influencing gene expression, signaling, and even 
apoptotic behavior of the cells, thus 3D models should strive to include multiple cell 
types to better represent the heterotypic environment present in the normal mammary 
gland as well as in tumors. Further, research is necessary to advance our knowledge of 





Development and use of 3D model systems has increased in the past decade. 
However, there is still a need to further enhance established 3D model systems by 
developing more modular model systems, reducing the production costs and the 
utilization costs, and increasing their result productivity. Globally, tissue cultures 
improved from cell culture conducted in petri dishes years ago to today’s state of cell 
culture conducted within 3D model systems. The latter approach is currently used to 
investigate the development of the normal and cancerous mammary gland, to understand 
the interactions that occur through cell-cell and cell-ECM interactions, to improve 
detection methods for cancer, and finally, to develop improved treatment methods for 






DEVELOPMENT OF A TUNABLE POLYMERIC MATERIAL FOR A 3D BREAST 
TISSUE MODEL 
Introduction 
Three-dimensional cell culture matrices, also known as scaffolds, were introduced 
to cell culture to help overcome 2D culture limitations [42]. These scaffolds are 
substrates that support cell growth, organization, and differentiation on or within their 
structure [42] and are composed of either naturally derived materials (e.g. collagen type I, 
rBM) or synthetic materials (e.g. polylactide). Such materials provide a 3D support to 
interact with cells to control their function, guiding the spatially and temporally complex 
multicellular process of tissue formation [43]. In designing scaffolds mimicking the 
natural ECM, an intricate interwoven fiber meshwork of collagen and elastic fibers 
embedded in a highly hydrated gel-like material of glycosaminoglycans, proteoglycans, 
and glycoproteins [42] is attractive, but other chemical, physical, and mechanical 
properties of the scaffold material influence cellular affinity and interactions. While all 
these properties must be taken into consideration, scaffold fabrication remains highly 
challenging as the in vivo remodeling process that is part of the tissue formation process 
to a large extent not take place in vitro [44]. 
Synthetic absorbable polymers allow cells to attach, spread, proliferate, and 
differentiate to form tissue [42]. As with all biomaterials, the nature of the scaffold itself 





properties of the material used in such a system affect its cellular affinity [126], 
absorption or degradation characteristics, and mechanical stability; these characteristics 
ultimately determine the suitability of a tissue engineering scaffold. Absorbable polymers 
such as polylactide (PL), polyglycolide, polycaprolactone, and their copolymers have 
been used over the past decades in medical applications, such as bone plates and screws 
[127], films [128, 129], and biodegradable sutures, and have been investigated for uses in 
tissue engineering. The word “polylactide” refers to a family of polymers that have 
varying degradation profiles and characteristics, depending on the structure and 
molecular weight of the polymer. Poly-L-lactide and poly-D-lactide are crystalline (i.e. 
generally comprised of ordered, more densely packed molecular chains), while 
copolymers of poly-D,L-lactide are normally amorphous (i.e. generally comprised of 
disordered, less densely packed molecular chains) [44]. These synthetic, absorbable 
polymers, typically characterized by their degradation profiles and initial molecular 
weight, are selected for use based on their mechanical and chemical properties depending 
on the target application. 
Processing of degradable materials plays a large part in the initial physical and 
chemical properties of these scaffolds and, accordingly, influences cell adhesion, 
migration, and differentiation. Therefore, activities focused on developing processing 
methodologies and techniques, understanding the relationships among device 
composition, structure, and the resulting degradation properties are crucial to understand 
and control cell–surface interactions in a 3D tissue engineering scaffold [130]. Beads 





drying, and cold precipitation techniques [131, 132]. Most commonly used are single or 
double emulsion technique (also called “oil-in-water” and “water-in-oil-in-water”, 
respectively) [131], which have been previously used to produce absorbable beads of 
polylactide, polyglycolide, polycaprolactone, and their copolymers for drug delivery 
applications. A single emulsion technique consists of dropping a solution of a hydrophilic 
polymer dissolved in a solvent (oil phase) into an aqueous solution containing a hardener 
such a polyvinyl alcohol (water phase) and stirring at a high rate to create hollow beads. 
Double emulsion techniques can be employed to encapsulate drugs or proteins in the 
polymer prior to bead formation; the beads can later be delivered in a controlled manner 
upon polymer degradation/absorption in the body [132]. Beads of injectable diameter, 
ranging from approximately 1 µm in diameter [133] to approximately 100 µm [134] have 
been reported [135-139]. The bulk and surface properties that are influenced by the 
processing variables impact cellular behavior. Some of the processing variables that 
affect bead properties include solvent type, solution volumes, processing vessel size, stir 
speed, and polymer composition [132]. Thus, when designing beads for tissue 
engineering applications, modulating processing techniques and methodologies to tune 
the scaffold is critical. 
Although both single emulsion and double emulsion techniques have been used to 
generate beads for drug delivery applications [131, 132, 140, 141], both techniques are 
being explored to produce larger, tunable beads of suitable size for cell seeding [47, 48, 
50, 126, 136, 142, 143]. With the prevalence of tissue engineering and the clinical 





properties are influenced by processing is important in developing scaffolds that support 
cells and maintain a microenvironment for viable tissue growth. To date, little work has 
been conducted to address the impact of polymer processing and the resulting structural 
changes on the performance of these materials with respect to cellular behavior [144]. In 
fact, most work focuses on cell response to absorbable materials with little to no regard 
for the dynamic material characteristics. Accordingly, this study was designed to assess 
specific processing variables in the production of polylactide beads and how changes in 
those variables affected bead formation and properties, specifically bead size, 
degradation, molecular weight, and crystallinity. Understanding how processing affects 
the material characteristics provides a way to produce polylactide beads that can be tuned 
for specific needs within the 3D breast tissue model. 
Materials and Methods 
Polylactide (PL) beads were produced in separate batches using a single emulsion 
technique. Three processing methods, Bead Fabrication Procedure 1, 2, and 3, were used 
to produce polylactide (PL) beads (Table 2.1). Each fabrication method had four separate 
conditions and within each condition four different batches of beads was produced. In 
Bead Fabrication Procedure 1, the effect of processing tank size and stir paddle size was 
observed. Processing tanks of 1L, 2L, and 6L volume were used with either a square stir 
paddle measuring 6.9 cm x 6.9 cm (large, Figure 2.1B) or an oval swivel blade paddle 
measuring 5.0 cm x 1.3 cm (small, Figure 2.1A). In Bead Fabrication Procedure 2, the 
effect of varying PL solution amounts, ranging from 10 mL in the smallest tank to 60 mL 





concentration of polyvinyl alcohol (PVA) was varied in the 2L tank using 20 mL of PL 
solution and the swivel blade paddle, ranging from 0.05 to 0.50%.  
 
Table 2.1 Specific parameters for Bead Fabrication Procedures. For every condition the stir 
speed (300 RPMs), stir time (90 minutes), and rinse times (10 minutes) were similar. All 
beads were washed in 2% Isopropanol solution over night on a shaker plate, placed on filter 
paper within a buchner funnel, then rinsed 3x with dH20. The beads were dried using a 

















I. Varied by Vessel Size 
1 
6 6.9 x 6.9 20 0.05 2000 
2 6.9 x 6.9 20 0.05 800 
2 5.0 x 1.3 20 0.05 800 
1 5.0 x 1.3 20 0.05 400 
II. Varied by PL Solution Amount 
2 
6 6.9 x 6.9 60 0.05 2000 
6 6.9 x 6.9 20 0.05 800 
1 5.0 x 1.3 20 0.05 800 
1 5.0 x 1.3 10 0.05 400 
III. Varied by PVA Concentration 
3 
2 5.0 x 1.3 20 0.05% 800 
2 5.0 x 1.3 20 0.10% 800 
2 5.0 x 1.3 20 0.25% 800 
2 5.0 x 1.3 20 0.50% 800 
 
As-received PL beads and post-processing beads were characterized using several 
methods, including imaging, gel permeation chromatography (GPC), differential 





evaluated by immersing beads in phosphate buffered solution (PBS) while crystallinity 
and thermal characterization properties were determined before immersion in PBS, and 
throughout the 49-day study. 
Polylactide Bead Processing 
Bead Fabrication Procedure I 
Polylactide (PL; NatureWorks LLC, Minnetonka, MN) pellets (2 g) were 
dissolved in 20 mL of dichloromethane (10% w/v; Mallinckrodt Baker, Inc, Phillipsburg, 
NJ) for 24 hours in scintillation vials (VWR International, West Chester, PA). A 0.3% 
(w/v) aqueous PVA solution (weight average molecular weight 13,000-23,000 Daltons 
(Da); Sigma-Aldrich, St. Louis, MO) and a 2% (v/v) isopropanol solution (Honeywell, 
Morristown, NJ) were prepared in 1 L pyrex bottles (Corning, Corning, NY). To make a 
0.05% PVA stir solution in the 6L tank, 1 L of aqueous PVA solution was added to the 
tank, followed by 5 L of distilled H2O (dH2O), to achieve a final volume of 6 L. The 
PVA solution was stirred at 300 RPM for 10 minutes using the square stir paddle. Using 
a 20 mL Luer-Lok™ syringe (BD, Franklin Lakes, NJ) with an attached 16-gauge needle 
(BD, Franklin Lakes, NJ), the polymer solution was injected into the PVA solution while 
stirring at 300 RPM with the needle tip submerged in the liquid at a 45° angle. The beads 
were stirred for 90 minutes at 300 RPM to ensure complete solvent extraction. The 
stirring was halted and the PVA solution drained until 1 L remained in the 6L tank. 
Subsequently, 2 L of 2% isopropanol solution was added and the beads were rinsed by 
stirring for 10 minutes. The remaining solution was drained and the beads were removed 





mL fresh 2% isopropanol. The bottle with beads was placed on a shaker plate for 24 
hours at 150 RPM, at which time the beads were placed on filter paper in a Buchner filter 
funnel (VWR International, West Chester, PA), rinsed with dH2O three times, dried in 
the chemical hood (Hamilton Concept from Fisher Hamilton LLC, Two Rivers, WI) 
under constant air flow produced by the suction of the house vacuum for 24 hours, and 
stored in a desiccator.  
 
  
Figure 2.1 (A) Bead processing tank set-up with small paddle. (B) Large paddle. 
Four batches of polylactide beads were produced consecutively on the same day 
to ensure similar processing conditions. For the 1L and 2L tank set-ups the processing 
was the same with the exception of solution volumes and paddle used (Table I). The 





solution, 750 mL and 1500 mL of dH2O, and 400 mL and 600mL isopropanol, 
respectively. The square stirrer paddle and the swivel blade paddle were used in the 2L 
tank, while only the swivel blade paddle was used in the 1L tank. 
Bead Fabrication Procedure II 
The protocol for Bead Fabrication Procedure I was repeated using varying PL 
solutions of 10, and 20 mL for the 1L tank and 20 and 60 mL for the 6L tank.  
Bead Fabrication Procedure III 
The protocol for Bead Fabrication Procedure I was repeated using varying PVA 
solution concentrations of 0.05, 0.1, 0.25 and 0.50% for the 2L tank with the swivel blade 
paddle.  
Bead Diameter Measurements  
A Lumenera 2-3C 3.3 MP camera (Lumenera Corp, Ottawa, ON, Canada) 
mounted on a stand and MatLab 7 (MathWorks, Natick, MA) were used to capture 
images of the PL bead batches produced by Fabrication Procedures I, II and III. 
AxioVision 4.7 software (Carl Zeiss AG, Germany) was used to measure the average 
diameter of 300 beads per batch. To account for different shapes and sizes, two 
measurements in perpendicular directions were taken for each bead. The mean and 
standard deviation of the bead diameters were calculated for all batches. 
Acellular Degradation Study 
The degradation properties of the beads produced by each of the processing 





Buffered Saline (PBS; Sigma, Milwaukee, WI) solution in each well of a 24-well cell 
culture plate. The well plates were stored in an incubator (37oC, 5% CO2). Throughout 
the study, aliquots of the PBS solution were taken weekly and analyzed using an YSI 
Biochemistry analyzer for lactic acid content; subsequently, the PBS solution was 
replaced. At each time point, after aspiration of the PBS, beads were collected from the 
well plates using a spatula and placed on filter paper in a Buchner filter funnel. The beads 
were rinsed with dH2O three times, dried in the chemical hood under constant air flow 
produced by the suction of the house vacuum for 24 hours, and stored in a desiccator 
until characterization was completed. Beads were characterized through molecular weight 
analysis, thermal analysis, and crystallinity determination. 
Molecular Weight Analysis 
Molecular weight was measured using gel permeation chromatography (GPC; 
Waters, Milford, MA). A Waters Breeze (Milford, MA) system equipped with a 
Refractive Index (RI) detector was used to assess PDL beads produced. The fluid pump 
for each was set to a rate of 1 mL/min. Polystyrene standards (Polysciences, Inc., 
Warrington, PA) with narrow weight average molecular weights (Mw), including 
1,000,000, 400,000, 233,000, 104,000, 50,000, 23,000, 4000, and 436 Da. were used. 
Samples were prepared in high performance liquid chromatography grade chloroform 
(Honeywell, Morristown, NJ) at a concentration of 1 mg/mL and filtered through a 0.2µμm 
Teflon membrane filter (VWR International, West Chester, PA). 
Number average (Mn) and weight average (Mw) molecular weights values were 





(PD), which is the molecular weight average to molecular number average ratio (Mw/Mn), 
was calculated for each bead type produced.  
Thermal Analysis and Crystallinity Determination 
A TA Instruments DSC 2920 (New Castle, DE) differential scanning calorimeter 
controlled by TA Instruments Thermal Advantage Software was used to thermally 
analyze PDL beads prior to immersion in PBS as well as at time points of 21 and 49 days. 
Beads were removed from the PBS at 21 and 49 days and placed on filter paper in a 
Buchner funnel and dried in the chemical hood under constant air-flow for 24 hours. 
Each sample (n=3), weighing approximately 5 mg, was heated from 0˚C to 200˚C in 
nitrogen at a rate of 10˚C per minute. Thermal transitions were analyzed using TA 











where fHΔ  is the measured heat of fusion, cHΔ  is the measured heat of crystallization, 
and ltheoreticafHΔ is the theoretical value for the heat of fusion of polylactide (92.9 J/g) 
[145]. Thermal glass transition temperatures (Tg) were taken at the onset, inflection, and 
end points; the inflection values are reported.  
Statistics 
JMP software (SAS Institute Inc., Cary, NC) was used to run a one-way Analysis 





Tukey-Kramer HSD for bead measurements, molecular weight analysis, and thermal 
analysis of polylactide beads produced in Bead Fabrication Procedures I, II, and III.  
Results 
Bead Diameter Measurements  
Bead Fabrication Procedure I determined how changes in the size of the vessel 
and the type of paddle used affected PL bead size and shape. PL beads with average 
diameters of 403±47, 544±96, 864±168, and 807±120 µm were produced in the 6L tank, 
2L tank with large paddle, 2L tank with small paddle, and 1L tank (Figure 2.2A), 
respectively. The shape of the beads changed depending on the vessel size and paddle 
size used to produce beads. The 6L tank produced the smallest size beads and also the 
beads that were most uniformly round (Figure 2.2D, 6L20). There was a significant size 
difference (p<0.01) between beads produced using the large vs. small paddle in the 2L 
tank. Beads produced in the 1L tank were similar in size to those produced in the 2L tank 
with the small paddle, however, comparatively fewer beads were abnormally shaped (e.g. 
peanut, dumbbell, tailed). 
Bead Fabrication Procedure II determined how increasing or decreasing the 
amount of PL solution in the processing protocol affects bead size. Beads with average 
diameters of 320±63, 403±47, 807±120, and 896±79 µm were produced in the 6L tank 
using 60 and 20 mL of PL solution and the 1L tank using 20 and 10 mL of PL solution 
(Figure 2.2B), respectively. Beads produced in the 6L tank and the 1L tank, regardless of 





between conditions within the same vessel. Comparing beads produced in the different 
vessels, the 6L60 beads were significantly different from both the 1L10 (p<0.001) and 
the 1L20 (p<0.01) beads. 
Lastly, in Bead Fabrication Procedure III, the concentration of the PVA solution 
was varied to look at the changes in bead size and shape. The most notable difference in 
beads produced in Bead Fabrication Procedure III is that as the PVA concentration 
increased, the average bead diameter decreased (Figure 2.2C) from 864±168 to 628±33 
µm and the different shapes (e.g. dumbbell, oval, tailed) were no longer present (i.e. the 
beads were all round) after the PVA concentration rose above 0.25% (Figure 2.2D 







Figure 2.2 Average diameter measurements of beads produced in Bead Fabrication 
Procedure I (A), II (B), and III (C) with representative images of PL beads (D; scale bar = 
1000µm), * p<0.05, ** p<0.01, *** p<0.001. Beads produced by Bead Fabrication Procedure 
I (6L20, 2L20B, 1L20, and 2L20s) demonstrate how vessel size and paddle size affect bead 
size and shape. Beads produced in Bead Fabrication Procedure III demonstrate how beads 
produced in each condition decrease in size as PVA concentration increases. As PVA 
concentration increases shape of beads becomes more round. Beads made with 0.05% and 





Acellular Degradation Study 
A bolus release of lactic acid was seen for all conditions through Day 14 and a 
much slower release of lactic acid through Day 49 (Figure 2.3) during the degradation 
study. Beads with the highest release of lactic acid were 2Lp5 beads followed by 2L20s 
and 1L10 beads. Beads with the lowest release of lactic acid over the 49-day period were 
6L20 beads. There was no correlation between the amount of lactic acid released and 
processing method or size of the bead. 
 
 
Figure 2.3. Lactic acid release for each condition over the 49-day degradation study 





Molecular Weight Analysis 
The same as-received PL pellets were used to produce beads for all Bead 
Fabrication Procedures. After processing, the molecular weight of the PL beads was not 
different from the as-received PL pellets. The as-received PL and Day 0 beads had 
similar average molecular weight (Mw) and polydispersity index (PD) values. All beads 
produced by Bead Fabrication Procedure I showed a significant difference (p<0.0001) 
from as-received PL after Day 21. At Day 49, 6L20 beads were significantly different 
(p<0.0001) from 2L20s and 1L20 beads, while 2L20B beads were significantly different 
(p<0.05) from both 6L20 and 1L20 breads. Significant differences (p<0.05) in PD were 
only seen at Day 49 between 6L20 and 1L20 beads. For Day 21 and Day 49 time points, 
beads produced in Bead Fabrication Procedure II were all significantly different 
(p<0.0001), except for 6L60 beads (p<0.01) at Day 21. At Day 49, no significant 
differences were seen when the amount of PL solution was increased in the 6L tank or 
decreased in the 1L tank. Bead Fabrication Procedure III beads showed a significant 









Figure 2.4 Comparisons of weight average molecular weight (A) and polydispersity index 
(B) of beads produced in each Bead Fabrication Procedure as a function of immersion time 





Thermal Analysis and Crystallinity Determination 
Processing affected the glass transition temperature (Tg, Figure 2.5A), 
crystallization temperature (Tc, Figure 2.5B), and melting temperature (Tm, Figure 2.6A) 
of the beads. As beads degraded, Tg and Tm gradually increased to values closer to as-
received PL over the 49-day degradation period, while the Tc only increased through day 
21 and then stabilized. The Tg of the as-received PL was significantly higher compared to 
all conditions, regardless of the processing method. At Day 21 Tg differences between the 
as-received PL were only seen in Bead Fabrication Procedure II with 1L10 beads 
(p<0.05) and in Bead Fabrication Procedure III with 2Lp1 beads (p<0.01). No Tg 
significant differences were seen between any bead types and the as-received PL at Day 
49, however, significant differences, p<0.05, were seen at Day 49 in both Bead 
Fabrication Procedure II between 6L60 and 6L20 beads and Bead Fabrication Procedure 
III between 2L20s beads and 2Lp1 and 2Lp25 beads. 
Crystallization temperatures (Figure 2.5B) were only compared across bead types, 
as the as-received PL did not have a Tc. In Bead Fabrication Procedure II there were no 
significant differences seen when the PL solution volume increased. In Bead Fabrication 
Procedure III, as the PVA concentration was increased the Tc decreased. The only 
significant difference was seen at Day 0, where 2L20s had a significantly higher Tc 
compared to concentrations of 0.1% PVA and higher. The largest differences in Tc were 
seen in Bead Fabrication Procedure I, where the vessel and paddle size changed between 
conditions, indicating that this variable in processing is very important. At Day 0, 1L20 





6L20 and 2L20B compared to all other conditions, whereas, beads produced with the 
smaller paddle (2L20s and 1L20) only showed a significant difference of p<0.01 
compared to each other. As the beads degraded all conditions showed increased in Tc. By 
Day 21, 6L20 was the only condition to have a Tc significantly higher than both 1L20 
(p<0.01) and 2L20s (p<0.0001). At Day 49, the Tc had much less variation within each 
condition of bead produced and thus there were significant differences seen based on 







Figure 2.5 Comparisons of glass transition (A) and crystallization temperatures (B) of beads 
produced as a function of immersion time (* p<0.05, ** p<0.01, and *** p<0.0001). 
Asterisks in a color other than black were used to differentiate between groups, e.g. in 
Procedure I had a statistically higher Tg compared to all other conditions, indicated by 






Figure 2.6 Comparisons of melting temperatures (A) and crystallization percentage (B) of 
beads produced in each Bead Fabrication Procedure as a function of immersion time 
(Statistical significance indicated by: * p<0.05, ** p<0.01, and *** p<0.0001). Asterisks 






The as-received PL had a significantly higher Tm compared to all conditions in 
Bead Fabrication Procedure I, II, and III (Figure 2.6A), however, no significant 
differences were seen between the conditions at Day 0 due to large standard deviations 
for all conditions except the as-received PL. Comparing conditions from Bead 
Fabrication Procedure I at Day 21, 2L20B had a significantly higher Tm compared to both 
2L20s (p<0.01) and 1L20 (p<0.05). Comparing conditions from Bead Fabrication 
Procedure III, at Day 21 2Lp5 had a significantly higher Tm compared to 2L20s 
(p<0.0001) and both 2Lp1 and 2Lp25 (p<0.01) indicating that even though 2Lp5 beads 
were produced in the highest concentration of PVA at 0.5%, a known plasticizer, the 
plasticizer is no longer present in the polymer after 21 days as shown by the increase in 
both Tg and Tm. 
Lastly, percent crystallinity was compared based on bead fabrication procedure. 
No differences were seen in beads produced in Bead Fabrication Procedure II, but 
significant differences were seen in both Bead Fabrication Procedure I and III. The beads 
with the highest percentage of crystallinity from Bead Fabrication Procedure I were the 
2L20s beads (22.9%) which was significantly higher compared to 1L20 (20%, p<.01), 
2L20B (14.4%, p<0.0001), and 6L20 (7.4%, p<0.0001) after processing. At Day 21 and 
49, beads produced using the small paddle had crystallinity percentages that were 
significantly higher (p<0.0001) than those produced using the large paddle, but no 
significant differences were seen between conditions made with the same paddle. When 
the PVA concentration was altered in Bead Fabrication Procedure III, the beads produced 





with the same paddle. However, at Day 0 the 2Lp5 beads had the highest cyrstallinity 
percentage of all beads (28.5%), which was significantly higher (p<0.01) than 2L20s 
beads. At the end of the degradation study, 2L20s beads were 15.5% crystalline and were 
significantly lower (p<0.01) compared to beads produced with a PVA concentration 
higher than 0.1%.  
In summary, the processing parameters that influence bead characteristics the 
most are the ratio of paddle size to vessel size and PVA concentration; however, the one 
material property not affected by processing is the molecular weight (Figure 2.7). 
 
 
Figure 2.7 Processing affects bead size, shape and thermal transitions, but not molecular 
weight as seen in Bead Fabrication Procedure I (A) and III (B) comparing bead size, 
















































































































































Fabrication of degradable polymer scaffolds for tissue engineering, not only for 
therapeutic applications but also for diagnostic applications, remains highly challenging 
[44]. Processing methodologies and techniques have been developed to produce scaffolds 
with varying compositions, surface modifications, and properties to target the location 
and use of the scaffold materials. Degradation is one of the major characteristics of these 
tissue engineered scaffolds and systems [129], where the degradation process is 
influenced by the size of the scaffold, the starting molecular weight of the material, and 
the crystallinity. The majority of manuscripts detailing the use of polymeric tissue 
engineered scaffolds report the as-received molecular weights; complete material 
characterization after processing and sterilization generally is not conducted [49, 146, 
147]. Characterization of the polymer post processing and post sterilization is crucial to 
provide a better understanding of the likely in vitro and in vivo performance of a given 
scaffold. Indeed subtle changes in material properties can cause radical changes in cell 
behavior [130]. Understanding the relationship between processing and post-processing 
material characteristics allow for tuning the production process to generate a scaffold 
suitable for a specific application. 
When producing scaffolds of designated shape and diameter, changes in 
processing should not alter the final product. Production of the PL beads in Bead 
Fabrication Procedure I demonstrate that processing changes i.e., paddle size and vessel 
size (Figure 2.7A) caused notable differences in the diameter of the beads produced. The 





diameter. In contrast, when the large paddle was substituted with a small paddle (2L20s) 
the beads produced had an average diameter of 864 µm. Thus, although the same 
protocol was followed, the final materials produced were significantly different.  
That observation suggested that other simple processing parameters routinely 
reported in processing protocols [132], such as solvent type, solution volumes, and 
polymer composition may also impact the final product. To assess this, Beads produced 
in Bead Fabrication Procedure II addressed whether the PL solution volume affected bead 
size. Bead diameters were not significantly different between beads produced in the 6L 
tank or the 1L tank regardless of the PL solution volumes. Stir solution concentrations 
were investigated by altering the PVA concentration. Increasing the concentration of the 
PVA solution decreased both the diameter of the beads and the number of non-spherical 
beads produced. While bead diameter measurements can be used to detect changes in 
processing, the size of the beads also impact material properties including degradation. 
Single emulsion methods used here were quite reproducible from batch to batch, 
however, a large distribution of bead diameters within each batch occurred in many of the 
conditions tested. Since degradation rate correlates to material mass, and therefore, bead 
size (i.e. diameter), a high within-batch variability corresponds to a variety of degradation 
profiles. This variability could be favorable for tissue-engineering applications, especially 
where a bulk release of by-products could be used to develop a microenvironment that is 
more representative of the breast cancer microenvironment. Bead size is a variable that 





the bead determine its suitability in a given application, but it also impacts the 
degradation profile of the system.  
Although size and shape of a tissue engineering scaffolds are important, the 
degradation profile is an additional property that requires careful consideration with 
respect to the intended application. The mechanical properties of a tissue-engineering 
scaffold change with the degradation profile. Practically, a scaffold should be treated 
before and after processing to remove lower molecular weight species. PL is a material 
that degrades by bulk degradation; thus, another bolus release of lactic acid will be 
released as the material fully degrades. Hence the cell-material interactions will vary with 
time and release of by-products. Some applications may require pre-degradation to ensure 
accelerated rates and full degradation of the scaffold [148], while other applications like 
use in a 3D in vitro model may need polylactide release at specific times to best represent 
the breast environment at a specific time. As our results indicate, even small material and 
processing changes affected the overall degradation profiles. Lactic acid measurements 
from aliquots of the PBS solution containing immersed acellular beads gave an indication 
of bead degradation. As the PL polymer chains in the beads were hydrolyzed into lactic 
acid monomers, the amount of lactic acid measured in the PBS immersion solution 
increased (Figure 2.3). With all bead types an initial bolus release of lactic acid within the 
first 14 days was observed, then the lactic acid release slowed considerably. Longer 
duration studies would enhance understanding of the lactic acid release profile and should 





Polylactides, thicker than approximately 0.80mm [149], undergo bulk degradation 
once implanted into the human body, where the molecular weight of the polymer starts to 
decrease. However, the volume of the polymer generally does not decrease until the 
molecular chains are reduced to a size where they can freely diffuse out of the polymer 
matrix [150-152]. Regardless of the thickness of the device, the first by-products to 
emerge will be those with the lower molecular weight [151]. As the PL beads degraded 
and concurrently diffused lactic acid in the PBS solution, a corresponding decrease in 
molecular weight of the beads was expected. Instead, here the beads produced 
demonstrated an increase in Mn and Mw. This may in part indicate the removal of 
impurities and lower molecular weight species from the as-received material, resulting in 
an increase in molecular weight and a decrease in polydispersity index. 
The molecular weight of a polymer influences how quickly the scaffold will 
degrade when used in different applications. The as-received material, processing vessel 
size, paddle type, and processing speed all influence the molecular weight of the beads; 
hence, each parameter should be adjusted to obtain the targeted outcome. For example, 
scaffolds used for injectable applications should have small diameters; thus, beads 
produced by emulsion solvent methods could be produced with a large vessel and paddle 
size and high spinning speeds. Another application may require beads with an accelerated 
rate of degradation; in this case processing PL beads using a small vessel may be more 
appropriate [148]. 
Crystallinity is another property of an absorbable polymeric scaffold that 





general have higher surface energies compared to amorphous materials; surface energy 
can impact protein absorption patterns and conformations, which stimulate specific 
cellular behaviors [128, 130, 153]. The PL beads had a lower average Tg (Figure 2.4A) 
than the as-received PL, likely due to the PVA and any remaining moisture in the beads 
acting as a plasticizer within the beads. As the beads degraded, the PVA was released 
from the beads and the Tg increased back to a temperature similar to the as-received PL. 
The significant differences seen in Tg, Tc, Tm, and crystallinity overall for the PL beads 
produced were caused by very tight standard deviations which caused the slightest 
change in temperature to be significant from the last. For example, the range of 
temperatures for Tm was 148-151˚C. 
The decrease in crystallinity seen in the beads produced in the Bead Fabrication 
Procedures can be explained by the polydispersity changes in the polymer chains over the 
49-day study. In Bead Fabrication Procedure I for example, the Mn of the 1L20 and 
2L20B beads decreased by almost 22 and 30%, respectively, while the Mw only decrease 
by 8 and 21%, respectively. The chain lengths stayed relatively constant in the 1L20 
beads and showed a slightly larger decrease in the 2L20B beads, while the number of 
chains decreased at similar rates. This suggests that as a relatively high number of shorter 
chains are removed, the longer chains do not have the opportunity to quickly rearrange, 
and thus a decrease in crystallinity is seen, albeit a less pronounced decline in the 1L20 
beads compared to the 2L20B beads. Because crystallinity affects the surface energy of 
the material and thus cellular behavior, it is crucial to purposefully select processing 





Processing materials is a challenge, as so many factors influence the 
physicochemical and mechanical properties of a given material. Results from this study 
showed that, of the variables studied in this research, the bead processing parameters of 
vessel size/paddle area and PVA concentration have the largest influence on bead 
diameters. While these are the main factors, they are not the sole factors. Paddle speed, 
solvent and solution concentrations, as well as polymer molecular weight, crystallinity, 
and polydispersity, all play a part in the resultant beads and their designated mechanical 
and physiochemical properties. A small change in processing can cause drastic changes 
in the final product, thus knowledge of how these parameters influence the outcome 
characteristics is crucial and can help enormously in producing tissue-engineering 
scaffolds that have tailored properties for their application. 
Summary 
While the focus of producing suitable degradable biomaterials for use in tissue 
engineering applications is at the forefront of materials research, development of 
methodologies and techniques to be used and the effects processing has on the bulk and 
surface properties of the material have yet to be thoroughly explored and detailed. Here 
we determined that both the vessel size/paddle size and PVA concentration have a 
significant effect on both bead size and shape. Thus, these two processing variables 
should be controlled regardless of the intended application. These observations highlight 
how each handling and/or processing step affects absorbable systems, both their chemical 





properties of multiple scaffolding materials and define how processing parameters can be 








Portions of results in this chapter were generated by an Institute for Biological Interfaces 
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of the Society For Biomaterials: McCave EJ, Kole D, Burg KJL: Development of a 
Heterogeneous In Vitro Three-Dimensional Breast Tissue Model. In: Society For 
Biomaterials 2014 Annual Meeting & Exposition: 2014 (Denver, CO; 2014) [3]. 
GENERATION OF THE STROMAL COMPONENT OF A 3D BREAST TISSUE 
MODEL USING EXTRACELLULAR MATRIX MATERIALS 
 
Introduction  
The human breast is a complex tissue composed of a glandular structure (the 
mammary gland) [7], consisting of a nipple, lobes, and ducts, surrounded by stromal 
tissue, fibrous and fatty tissue. The mammary gland is a dynamic structural tissue that 
changes, beginning with the formation of the lobule bud structure during neonatal 
development, continuing with the development of alveoli or acini during adolescent 
puberty, then full lobulo-alveolar development with child birth, followed by involution at 
the end of lactation [8]. The stroma, i.e. the fatty and connective tissue, surrounds the 
lobes of the glandular tissue [7]. The breast contains very little muscle and is mainly 
composed of stroma, which defines the shape and size of the breast [7, 9, 11]. 
The stroma is not an inert tissue. The composition and organization of the ECM 
and cellular components evolve with the developmental stages of the mammary gland 
[13, 24]. Thus, the variations in epithelial-stromal interactions and ratios that occur 
during the various stages of breast development influence the components of cellular 





including gene expression accounting for the susceptibility or risk to develop breast 
cancer [99, 106]. While research has focused on epithelial-stroma interactions and how 
they influence the proliferation, the differentiation, and, at times, the quiescence of the 
epithelial cells and their progenitors, there is still much that is unknown. In vitro model 
systems have been developed, through the use of tissue engineering methods (reviewed in 
[107]), to better understand the development and structure of the gland parenchyma and 
how the stroma influences development and even breast cancer initiation and progression. 
Tissue engineering, i.e. the construction of tissues using cells and biomaterial 
“scaffolds” or “matrices” as foundational building blocks, has been of interest for many 
years for mammary reconstruction following mastectomy or lumpectomy [154, 155], and 
has been investigated more recently for use in building 3D mammary tissue models 
[107]. The intricacies of mammary tissue have provided numerous challenges in tissue 
engineering. The mammary gland is a complex tissue comprised of epithelial parenchyma 
embedded in an array of stromal cells that regulate its proliferation, differentiation, and 
survival [8]. The fibrous connective tissue of the stroma, also known as the ECM, is a 3D 
network that surrounds the cells and is of two types. The first constitutes the basal 
membrane (BM), which interacts directly with the epithelium and consists primarily of 
globular collagen IV, laminin, entactin/nidogen, and heparan sulfate proteoglycans. The 
second forms the interstitial matrix, which consists of fibrous collagen (usually Type I 
and III) and fibronectin [25]. The latter contributes to the mechanical strength of the 
tissue [25]. Luminal epithelial cells line the ducts and are surrounded by a layer of myo-





epithelial-lined ductal structure and the surrounding connective and fat tissue. The ECM, 
largely through its dynamic chemical and mechanical characteristics, is able to regulate 
cell shape, proliferation, polarity, differentiation, transcription, synthesis, and secretion 
for a variety of cell types [106]. 
Epithelial cell monolayers have traditionally been used to study breast cancer, yet 
two-dimensional (2D) cultures only partially reproduce the structure or the function of 
the mammary epithelium in vivo [81]. Thus, 3D cultures have been developed to better 
represent the in vivo environment. Much of breast biology and breast cancer research has 
included mammary epithelial cells or breast cancer cells embedded in ECM component 
mixtures such as collagen Type I, reconstituted basement membrane products (rBM, e.g. 
Matrigel™), or a combination of the two, to mimic the breast ECM [79-81, 94]. 
Dhimolea and colleagues found that flexible Type I collagen matrices supported 
polarized acini and branching ducts when human breast epithelial (MCF10A) cells and 
human mammary fibroblasts obtained from reduction mammoplasties (RMF) cells were 
suspended in the gels in co-culture [79]. Krause and colleagues co-cultured MCF10A and 
RMF cells embedded in a Type I collagen gel, which resulted in the development of 
branched ducts, but when rBM was added to the collagen in a 1:1 ratio, branching ducts 
and alveoli were produced [81]. Dréau and coworkers [95] found that the behavior of 3D 
cultures of normal murine mammary gland (NMuMG) cells, cultured either alone or in 
combination with mouse mesenchymal stem cells (D1), were dependent on the “matrix” 
or surrounding biomaterial environment consisting of agarose, collagen, or Matrigel™ 





cultures grown in combination matrices of Matrigel™ and collagen I when compared to 
cultures grown in Matrigel™ or collagen I alone. No tubular structures were formed 
when agarose was included in the matrix, regardless of the combination. These works 
highlight the process of acinar and ductal formation, demonstrating how epithelial cells 
react in different gel environments, highlighting the fact that the surrounding 
microenvironment plays a particular role in normal ductal formation and overall 
regulation of ductal branching and lobular formation in the breast. 
The objective of this work was to develop a heterogeneous in vitro 3D breast 
tissue model. This model will be used as a proof of concept of a modular research model 
system. Gels of different compositions and concentrations, seeded with mammary 
epithelial cells, were used to develop the stromal component of the 3D breast tissue 
model. Three hydrogel matrices, Agarose, Collagen Type I, and Matrigel™, were 
assessed for use as the 3D tissue model stromal component. Cell viability and generation 
of acinar-like structures was assessed following seeding with MCF10A cells. The most 
appropriate hydrogel was selected. This study, first determined the most suitable 
component(s) for the base of the 3D model and second defined the optimal hydrogel 
concentration for the 3D system. 
Materials and Methods 
Cell Culture and 3D Constructs 
Normal breast epithelial cells (MCF10A; ATCC, Manassas, VA) were cultured in 





supplemented with 10% Fetal Bovine Serum (FBS; Corning, Manassas, VA), 1% 
Fungizone (Life Technologies, Grand Island, NY), 5% antibiotic/antimycotic (Life 
Technologies) and Clonetics® MEGM® SingleQuots® (Lonza, Walkersville, MD) 
supplements including: 2.0 mL BPE, 0.5 mL hEGF, 0.5 mL hydrocortisone, 0.5 mL 
insulin, and 0.5 mL GA-1000. While in 2D culture, medium was changed every 2-3 days. 
Once cells were approximately 75% confluent, they were trypsinized (Corning) spun 
down, and resuspended at 6x106 cells/mL. To generate the 3D culture systems three 
hydrogel materials: agarose (Lonza,Rockland, ME), collagen Type I (BD Biosciences, 
Bedford, MA), and Matrigel™ (BD Biosciences) at 1.6% (w/v), 1.6 mg/mL, and 1.6 
mg/mL, respectively, were used either alone or in combination as the conditions for the 
3D constructs based on previous work by Swamydas et al. [95]. An initial layer (150 µL) 
of the 3D system components were plated in 8-well chamber slides (Nunc, Rochester, 
NY) and gelled in an incubator (37°C, 5% CO2) for 30 minutes to provide a base layer in 
the system to prevent cells from attaching to the bottom of the well. Then a top layer of 
300 µL was mixed with 20 µL of cell suspension (6x106 cells/mL) and plated on top of 
the base layer. Constructs were placed in the incubator and medium added after 24 hours. 
Medium was changed every 3 days. MCF10A cells were grown for 10 days within each 
system and evaluated for cell viability and acinar-like and ductal-like structure formation.  
To determine the concentration of the base model 3D system, MCF10A cells 
(1.2x105 cells/well) were mixed with collagen Type I and Matrigel™ (1:1 v/v) at 1.6, 2.4, 
3.2, and 4.0 mg/mL concentrations, using the above method of a bi-layer design. Medium 





day 10. Repeating Live/Dead and histological analysis of the gels to determine the 
optimal concentration. 
Live/Dead Assay 
Cell viability was assessed using a LIVE/DEAD® cell viability kit (Invitrogen, 
Eugene, OR) according to the manufacture’s protocol. A Live/Dead assay solution using 
a ratio of 2 mL of Dulbecco’s Phosphate Buffered Saline (PBS; Sigma, St. Louis, MO) to 
1 µL of 4mM calcein-AM stock and 4 µL of 2 mM EthD-1 stock was prepared. After 30 
min incubation with the Live/Dead assay solution the solution was removed and gels 
were fixed in 4% paraformaldehyde (Sigma) for 30 minutes. Constructs were rinsed 
twice with PBS to remove any remaining paraformaldehyde. A Zeiss Axiovert 40 (Carl 
Zeiss MicroImaging, Gottingen, Germany) inverted fluorescent microscope was used to 
capture representative fluorescent images of cells within the 3D constructs. Images were 
analyzed using Image J (National Institutes of Health) cell count plug-in. 
Cell Cluster Measurements 
Phase contrast images of the 3D constructs containing cells were taken at the 
same time as the Live/Dead assay. Images were captured on a Zeiss Axiovert 40 inverted 
microscope. Using the outline tool in the Zeiss AxioVision software (Version 6.4, Carl 
Zeiss) borders were drawn around the cell clusters and the corresponding area of the cell 






Histological 3D culture samples were fixed in 4% paraformaldehyde and frozen 
sectioned. Hematoxylin and Eosin (H&E, Richard Allan Scientific, Thermo Fisher 
Scientific, Kalamazoo, MI) staining was used to evaluate the acinar and ductal-like 
structure formation within the 3D constructs. A semi-quantitative analysis on a scale of 0-
3 with 0 representing clusters with 2 or fewer cells, 1 representing clusters with 2-5 cells, 
2 representing 5 or more cells [156] with partial polarization, and 3 representing clusters 
with 5 or more cells with full polarization (full acinar structure formation) was used to 
evaluate acinar structure formation in different construct conditions and concentrations. 
A similar scale was used to evaluate ductal-like structure formation.  
Immunofluorescence was used to evaluate the expression of E-cadherin (e.g. 
confirmation of acinar-like structures and polarization of these cells in the clusters) and 
Ki-67 (i.e., cell proliferation). Slides were rehydrated using a series of rinses (2X each) in 
distilled H2O (MilliQ, Darmstadt, Germany), PBS, and 0.2% Tween 20 (Bio-Rad, 
Hercules, CA) in PBS. A 1:1 solution of 5N hydrochloric acid (HCl; Ricca Chemical 
Company, Arlington, TX) and PBS was placed on the samples for 15 minutes to 
permeabilize the cells. Slides were rinsed 2X with 0.02% Tween 20 and then blocked 
using 10% goat serum (Sigma) for 30 minutes. The first primary antibody, E-cadherin 
(1:1600 in 1% goat serum, Pierce™ Thermo Scientific, Rockford, IL), was placed on the 
samples at incubated at room temperature (RT) for 2 hours. The primary antibody was 
removed and the secondary antibody, Alexafluor® 594-conjugated AffiniPure F(ab’)2 





West Grove, PA), was added to the samples and incubated overnight at 4°C. Alexafluor® 
594 was removed and a second primary, Ki-67 (1:1000, Pierce™) was added for 2 hours 
at RT. Alexafluor® 488 goat anti-rabbit IgG (H+L, 1:200; Life Technologies, Eugene, 
OR) was incubated on the samples overnight at 4°C. Samples were rinsed twice with 
PBS and ddH20. Slides were mounted with ProLong Gold® antifade reagent with DAPI 
(Life Technologies). Slides were allowed to dry and imaged using a Zeiss Axiovert 40 
inverted fluorescent microscope. E-cadherin was evaluated semi-quantitatively using a 
scale of 0-3, 0 indicating no expression and 3 indicating expression within cell clusters 
containing 5 or more cells. Single cells and cell clusters containing 4 or fewer cells were 
excluded from the analysis. Expression of Ki-67 was evaluated by counting the number 
of cells that were expressing the Ki-67 protein. A total cell count was taken in order to 
determine the percentage of Ki-67 positive cells.  
Statistical Analysis 
JMP software (SAS Institute Inc., Cary, NC) was used to run a one-way Analysis 
of Variance (ANOVA, α=0.05) to analyze differences comparing all pairs using post-hoc 
Tukey-Kramer HSD for differences in 3D construct conditions as well as between 3D 
construct component concentrations for cell viability, cell cluster measurements, and 
histological analysis. 
Results 
To determine the most suitable stromal component(s) to use in the 3D breast 





combination and seeded with MCF 10A cells. This combination of hydrogel material and 
cells formed the stromal component constructs. A series of analyses were used to 
optimize the type of hydrogel material(s) and the concentration of those components to 
use in the 3D breast tissue model starting with cell viability. Cell cluster measurements 




Figure 3.1 Optimization of the component(s) and concentration to be used for the 3D breast 
tissue model stromal component. 
Part I – Determination of Stromal Component(s) 
Live/Dead Analysis 
Live/Dead analyses indicated that differences in stromal conditions led to 
alterations in cell viability and morphology. Conditions that decreased cell viability 





However, the effects of these stroma conditions on cell viability and morphology were 
not significantly different from one another. The stromal component condition produced 
from a 1:1:1 ratio of Agarose, Collagen, and Matrigel™ (ACM) had an average MCF10A 
cell viability of 74.18±10.69%. All other stromal component conditions had a cell 
viability over 75%, including Agarose/Matrigel™ (AM), Collagen/Matrigel™ (CM), and 
Matrigel™ alone  (M) with 85.3±6.1%, 88.0±7.9% and 93.1±4.4%, respectively. AM, 
CM, and M conditions were not significantly different from each other, but were 
significantly different from ACM, C, AC, and A stromal component conditions (Figure 
3.2). The average for Agarose/Collagen/Matrigel (ACM) was below 75%, but could not 
be excluded confidently as determined through statistical analysis. Cell viability for AM, 
CM, and M conditions were not significantly different from each other, but CM and M 
were significantly different (p<0.0001) from ACM, C, AC, and A stromal component 








Figure 3.1 Average percentage of cell viability (** p<0.01, *** p<0.0001). Conditions with 
cell viability less than 75% were excluded from further analysis.  
Histological cell analyses indicated multiple cells clustered together in all 
conditions, with larger cell clusters being present in M constructs. The only condition to 
show cells spread across a distance, which indicates ductal-like structure formation, in the 
cell viability assay occurred in CM constructs (Figure 3.3). Conditions that contained 
Agarose had fewer cells in a single plane compared to conditions that did not contain 




































Figure 3.3 Live/Dead microphotographs depict cell viability in each condition 
(magnification = 50x, scale bars = 200µm); (A) Agarose condition – lowest cell viability, 
(CM) Collagen/Matrigel™ condition showing the ductal-like structures, (M) Matrigel™ 
condition – highest cell viability. Cells were imaged in multiple planes within the constructs 
to get a representative cell cluster count for cell viability.  
After exclusion of conditions with a viability of 75% four stromal component 
conditions, ACM, AM, CM, and M, were further analyzed for cell cluster measurements 
and histological analysis to determine the most appropriate stromal components for the 
model. 
Cell Cluster Measurements 
Cell cluster measurements were divided into categories of single cells/small 
clusters (0-125 µm2), medium sized clusters (126-500 µm2), large clusters (500-2000 
µm2), and extra-large clusters (>2000 µm2). These structures were confirmed using H&E 
staining. The greatest number of cell clusters (n=4285) were found in M constructs, but 
the cell clusters formed at the intersection of the top and bottom layers of the construct 
leaving all the cell clusters in focus at once. All other construct conditions, AM, ACM, 
and CM, had cells and clusters that were distributed throughout the 3D constructs. The 





(Figure 3.4) that fell within the category of large clusters with 48.4±6.5% and 48.5±6.5% 
respectively, which was significantly higher (p<0.01) than both ACM and M construct 
conditions. The ACM constructs had the lowest percentage (18.9±2.6%) of large clusters. 
 
 
Figure 3.4 Percentage of cell clusters by size in conditions with cell viability above 75%.  
Histological Analysis 
Histological sections of the constructs were stained with H&E to assess the 
presence of acinar and ductal-like structures. Ductal-like structures were observed in CM 





throughout M based constructs, where cells settled on the bottom layer of the gel 
constructs.  
Immunofluorescence staining was used to evaluate cell proliferation (Ki-67) and 
acinar polarity (E-cadherin) in the stromal component constructs. Regardless of stromal 
component conditions, low percentages of Ki-67 positive cells indicative of low cell 
proliferation were measured (Table 3.1). ACM constructs had the lowest cell 
proliferation after 10 days in culture with 0.40% and M constructs the highest with 
1.25%. E cadherin staining was conducted on cell clusters with 5 or more cells, scored on 
a scale of 0-3. M constructs had the highest semi-quantitative score and ACM with the 
lowest (Table 3.1). Agarose containing constructs, ACM and AM, had very few cell 
clusters containing 5 or more cells, 0 and 16 clusters respectively, whereas the Matrigel™ 
containing constructs had more cell clusters of 5 or more cells. Some M clusters 
contained over 10 cells per cluster and many of the clusters were polarized with cell 
nuclei oriented around the outer edge of the clusters with an open center (Figure 3.5).  
 
Table 3.1 Histological analysis of the effects of stromal component conditions on both cell 
proliferation and cell cluster polarity as determined by Ki-67 and, E-cadherin staining, 
respectively.  
Cond 
Ki-67 Counts E-cadherin Scoring Categories Total 
Score #Cells # Pos % Pos 0 1 2 3 
ACM 250 1 0.40% 0 0 0 0 0.0 
AM 473 4 0.85% 14 2 0 0 12.5 
CM 655 8 1.22% 15 12 6 0 72.7 







Figure 3.5 E-cadherin staining showing polarity of cell clusters for ACM, AM, CM, and M  
(nuclei in blue and E-cadherin in red). Magnification = 100x, scale bars = 100 µm. 
Part II – Determination of Stromal Component Concentration 
From Part I of the study, constructs of Collagen/Matrigel™ were selected for the 
stromal component of the 3D breast tissue model. Next, the concentration of the stromal 
component must be determined. Initial concentrations of 1.6, 2.4, 3.2, and 4.0 mg/mL 
were considered. Concentrations with cell viability below 75% were eliminated and then 
cell cluster measurements and histological analysis were conducted to inform the 






Cell viability based on the stromal component concentration was evaluated with a 
Live/Dead analysis. Collagen/Matrigel™ constructs produced with concentrations of 4.0 
mg/mL led to the lowest cell viability i.e., below 75% and significantly lower (p<0.0001) 
than the cell viability observed in Collagen/Matrigel™ at concentrations of 1.6, 2.4, and 
3.2 mg/mL, respectively. The 2.4mg/ml Collagen/Matrigel™ construct reliably (low 
variability) produced led to the highest cell viability (78.3±3.4%, Figure 3.6). 
 
 
Figure 3.6 Cell viability within 3D construct produced from different concentrations, 

































Cell Cluster Measurements 
The 1.6 mg/mL concentration of Collagen and Matrigel™ had a significantly 
higher (p<0.01) percentage of cell clusters in the 501-2000 µm2 range, with 66.2±8.2% 
(n=935) of clusters falling within this range. A lower percentage of large area clusters 











Hematoxylin and Eosin staining showed that Collagen/Matrigel™ constructs with 
a concentration of 2.4 mg/mL had both acinar and ductal-like structures whereas only 
acinar-like structures were observed in constructs generated using CM at 1.6 or 3.2 
mg/mL concentrations (Figure 3.8). Of note, many of the cells and cell clusters were 
found as a single layer at the intersection of the top and bottom layers of the construct in 
the 1.6 mg/mL concentration. In contrast, the constructs generated with CM at 2.4 and 
3.2 mg/mL concentrations had more uniformly distributed cells and cell clusters. 
However, in the CM 2.4 mg/mL constructs the ductal-like structures mainly formed at the 
intersection of the bottom and top layers. The construct generated from CM 3.2 mg/mL 







Figure 3.8 H&E staining of 1.6, 2.4, and 3.2 mg/mL stromal component concentration 
constructs (top row: magnification = 50x, scale bars = 200 µm; bottom row: magnification = 
200x, scale bars = 50 µm). 
Immunofluorescence staining was used to evaluate cell proliferation (Ki-67) and 
acinar polarity (E-cadherin) in the remaining CM constructs produced at concentrations 
of 1.6, 2.4, and 3.2 mg/mL. Regardless of stromal component conditions, low 
percentages of Ki-67 positive cells indicative of low cell proliferation were measured 
(Table 3.2). CM constructs of 3.2 mg/mL concentration had the lowest cell proliferation 
after 10 days in culture with 0.82% and 1.6 mg/mL concentration constructs the highest 
with 1.18%. E cadherin staining was conducted on cell clusters with 5 or more cells, 
scored on a scale of 0-3. Constructs produced from 3.2 mg/mL components had the 
highest semi-quantitative E-cadherin score, 88.4, closely followed by the 2.4 mg/mL 
concentration at 76.1, while the 1.6 mg/mL concentration had the lowest score at 40.4  





intersection of the bottom and top layers of the construct (Figure 3.9). These cell clusters 
did not demonstrate as much polarization as the 2.4 and 3.2 mg/mL concentrations cell 
clusters containing 5 or more cells. In the 2.4 and 3.2 mg/mL concentration constructs 
many of the clusters were polarized with cell nuclei oriented around the outer edge of the 
clusters with an open center (Figure 3.9).  
 
Table 3.2 Histological analyses of stromal component concentrations 
Conc 
Ki-67 Counts E-cadherin Scoring Categories Total 
Score # Cells # Pos % Pos 0 1 2 3 
1.6 844 10 1.18% 33 10 3 1 40.4 
2.4 780 9 1.15% 12 33 1 0 76.1 
3.2 736 6 0.82% 19 11 12 1 88.4 
 
 
Figure 3.9 DAPI staining from Ki-67/E-cadherin staining showing polarity of cell clusters 
found in 1.6, 2.4, and 3.2 mg/mL concentration constructs (magnification = 100x, scale bars 
= 100 µm). 
Based on consistency, a cell viabilty greater that 75%, cell cluster measurements 
that indicate the formation of cell clusters containing 5 or more cells, and histological 
analysis of the cell clusters constructs formed using CM at a concentration of 2.4 mg/mL 
is optimal for use in our 3D breast tissue model.  





Table 3.3 An overview of why the 2.4 mg/mL Collagen/Matrigel™ concentration was 
selected for the 3D breast model stromal component. 
 
Discussion 
The objective of this study was to optimize the stromal component(s) and 
concentration for the 3D model system to best represent the normal microenvironment of 
the breast. The stromal components of Agarose, Collagen Type I, and Matrigel™ were 
chosen based on their prevalent use in 3D model systems [79-81, 94, 95, 150]. All three 
materials chosen have limitations and challenges. Agarose is stiffer than the other 
materials and only allows limited cell movement and growth. Collagen is remodeled 
quickly and alterations in the gel structure and stiffness are observed in short periods of 
time. Lastly, Matrigel™ is a complex ECM with somewhat variable composition derived 
from tumors, which may include components that adversely affect cell growth within the 
Collagen/Matrigel™ 
Concentration  1.6 mg/mL 2.4 mg/mL 3.2 mg/mL 
Cell Viability Cell viability above 75% 
Highest cell viability 
(78.35%) with lowest 
variability 






percentage of cell 
clusters in the 501-2000 
mm2 range 
29% of cell clusters fell  
in the 501-2000 mm2 
range 
14.9% of cell clusters fell  





Acinar structures formed 
mostly at the intersection 
between construct layers 
Only concentration to 











3D stromal constructs. Thus we tested different combinations of Agarose, Collagen Type 
I, and Matrigel™ in varying ratios and densities to produce different constructs. 
In producing the 3D constructs, we added a bottom layer of the component(s) to 
prevent cells from settling out of the construct and attaching to the bottom of the 8-well 
chamber slides. If the cells settled out of the constructs, then in Chapter 4, the polylactide 
beads that are added to the 3D constructs would also settle out providing an environment 
that was more 2D than 3D for the cells cultured. Also, in preliminary studies, if 
constructs were produced without the bottom layer they would detach and begin floating 
in 3-5 days. This is problematic because it affects the mechanics of the microenvironment 
and the mechanical forces the cells sense in the constructs [157].  While a detached gel 
model is successful in modeling breast cancer [45, 46, 67, 79], our model was intended to 
stay anchored in the 8-well chamber slides. To prevent this from happening a thin bottom 
layer was added to the constructs to ensure attachment of the constructs for 10 days. 
Dhimolea and colleagues found that after 10 days in culture, MCF10A cells contraction 
of collagen gels decreases and the risk of the gels floating reduces greatly [79]. 
Monitoring cells in 3D presented some unique challenges. For example, 
Live/Dead analysis of the cells required longer incubation time as the dye solution had to 
diffuse throughout the constructs before cells could be effectively stained. One of the key 
technical limitations of the microscopic analyses of the 3D cell culture conditions is the 
monitoring of 3D structures spanning multiple microscopy planes. Similar challenges are 
inherently present in the histological analyses of those 3D structures. Approaches to 





provided additional information regarding cell location and organization in the conditions 
tested.  
Based on the cell viability criterion (i.e., above 75%), observations in Part I of this 
study led to the removal of constructs generated from A, C, and AC from further 
consideration. As expected, constructs containing Agarose led to low cell viability partly 
because they only allow limited movement and growth of the cells. Collagen I based 
constructs also led to low cell viability (below 75%). Indeed, while Collagen Type I is 
one of the main components of the breast, it has been shown that cell viability is reduced 
in constructs made solely from Collagen Type I [159]. Matrigel™ containing constructs 
performed as described previously in many of the assays conducted [95, 160]. Matrigel™ 
is used in many 3D cultures because of the cellular response to the material [94, 160, 
161]. While the Matrigel™ used in the constructs tested here is growth factor reduced, it 
is nevertheless an ECM secreted by tumor cells, with inherent variability in the 
composition of ECM components and factors presents [161]. Here, Matrigel™ alone 
based constructs were found to be a challenging 3D environment mostly due to the lack 
of thickness the construct provides (Figure 3.5) that prevented incorporation of 300-
425µm diameter polylactide beads (see Chapter 4).  
The remainder of the analyses were performed on constructs selected on the basis 
of cell viability, all of them containing Matrigel™. Cell cluster measurements revealed 
that AM and CM based constructs led to the formation of the highest percentage of cell 
clusters with area measurements in the large range of 501-2000 µm2. While M based 





respectively), it led to the lowest percentage of large-range cell clusters. In contrast with 
other constructs, in the M based constructs, cells formed a compact cell layer facilitating 
the microscopic monitoring of both single cell and cell clusters. In AM and CM based 
constructs single cells and cell clusters were dispersed in multiple focal planes and 
averaged between 10 and 50 cell clusters per stack of fields of view.  
H&E staining of the ACM, AM, CM, and M based constructs confirmed that in M 
based constructs the cells seeded onto the top of the bottom layer and grew at the 
interface between the 2 layers of the constructs. In all other constructs cells dispersed 
throughout. ACM based constructs had smaller cell clusters, likely due to the presence of 
Agarose that form a stiffer matrix holding cells in place and preventing matrix 
remodeling as mammalian epithelial cells typically do not express the enzyme (agarase) 
to break down agarose [160]. Agarose molecules within the construct limit interactions 
and remodeling of collagen and other matrix compounds present in Matrigel™ [160]. 
Agarose also by limiting cell interactions and signaling by ECM compounds prevented 
cell proliferation as suggested by low Ki-67 staining. The most Ki-67 positive cells were 
observed in M constructs and can be contributed to Matrigel™ composition that provides 
a 3D microenvironment for cell growth and proliferation, but also acted as a 2D 
substratum allowing cells to concentrate in limited area thereby increasing inter-cell 
signaling resulting in both proliferation and acinar structure formation. This interpretation 
is supported by the observations that in M based constructs cells also formed the most E-





Next, the optimal Collagen/Matrigel™ (CM) concentration to be used in 
constructs was determined. Initial constructs with CM concentrations of 1.6 to 4.0 
mg/mL were derived from previous work by Swamydas and colleagues [95]. The initial 
constructs using a CM concentration of 1.6 mg/mL was selected based on the stiffness of 
the material and its ability to incorporate polylactide beads without breaking apart or not 
covering the beads completely as it settled while gelling. CM constructs with 
concentrations greater than 4.0 mg/mL are significantly more stiff [162]. However, such 
stiffness is significantly higher than those measured in normal breast tissues and thus 
were excluded from the present study. Three criteria for the stromal component 
concentration of the constructs were used to determine the optimal constructs: (1) cell 
viability within the constructs, (2) cell formation of acinar and ductal-like structures, and 
(3) proper polarization of the formed structures.  
Live/Dead assays demonstrated that the cell viability significantly decreased in 
CM-based construct generated with 4.0 mg/mL compared to CM based constructs made 
with either 1.6, 2.4 or 3.2 mg/mL. The observed decrease in cell viability likely has 
multiple causes including possibly the consequence of a decreased nutrient diffusion but 
more likely the absence of appropriate microenvironment cues [92].  
As the concentration of CM increased in the constructs tested, a decrease in the 
size and number of clusters was observed. However, in the 1.6 mg/mL CM derived 
constructs, cells settled to the bottom of the top layer producing a dense layer of cells at 
the interface between the two layers of the construct. In those conditions, larger cell 





rest of the construct. In the CM constructs derived from 2.4 and 3.2 mg/mL 
concentrations, cell clusters were smaller, but more dispersed throughout the top layer of 
the construct. Additionally, in the 2.4 mg/mL CM derived constructs, ductal-like 
structures were observed mostly at the interface between the bottom and top layers (as 
seen in Figure 3.8). Some ductal-like structures had cell nuclei that oriented around an 
open middle that carried over a distance greater than 3-4 cells. In both H&E and 
fluorescent histological sections, these structures were shaped like commas, where at 
least one end was tapering while either the center had more space or the opposite end was 
rounded out similar to a terminal end bud. 
The histological analysis conducted confirmed the cell viability and cell cluster 
measurement results. Ki-67 expression was not expected to be prevalent by day 10 within 
the constructs as most cells in clusters would be in the process of differentiating or if they 
were located at the center of a cluster, they may be in the process of apoptosis. Single 
cells that were isolated would not be proliferating unless they had the right cues from 
nearby cells and cell clusters. E-cadherin expression should only be observed in cell 
clusters that are in the process of becoming polarized or differentiating. Results showed 
that E-cadherin expression increased as the concentration of Collagen and Matrigel™ 
increased. One explanation might be that in order for cell polarization and differentiation 
within the cell clusters the cells must be in a stiffer environment or provided signals from 
adjoining cells through cell-cell junctions.  
Basecd on the data gathered in the present study, the optimal 3D matrix 





Matrigel™ at a concentration of 2.4 mg/mL. This CM derived construct provided 
MCF10A cells a microenvironment compatible with cell survival, proliferation and 
differentiation into organized acinar and ductal-like structures.  
Summary 
Optimal MCF10A cell growth occurs in 3D constructs derived from combined 
collagen I and Matrigel™, Therefore, these components will serve as the stromal matrix 
of the heterogeneous 3D breast tissue models (see Chapter below). The next studies 
further our understanding of how combinations of matrix components and polylactide 
microspheres modulate cell viability. Additionally, normal and cancerous cell behavior is 









A COMPOSITE 3D BREAST MODEL TO DETERMINE THE EFFECTS OF 




Much research using breast tissue models has been conducted to understand how 
cells become cancerous in the mammary gland, propagate, and eventually metastasize in 
the body. While this research has provided a better understanding of the underlying 
mechanisms associated with normal mammary gland function and breast cancer, our 
understanding of the extracellular matrix (ECM)-cell interactions during normal breast 
tissue and malignant development remains unclear. Model systems currently in use 
include clinical and in vivo models, two-dimensional (2D) in vitro models, and three-
dimensional (3D) in vitro culture models. In recent years, 3D model systems have been 
developed for numerous normal tissues and pathologic conditions. Ranging from the use 
of tissue tumor explants to cell lines in homo or heterotypic cultures, 3D in vitro culture 
systems provide information on the role of mesenchymal cells, the matrix composition, 
and density in the formation of acinus- and duct-like structures. However, the need for 
reliable, versatile, and reproducible 3D in vitro model systems that allow the modulation 
of the ECM properties remains. 
In the normal breast, cellular and ECM components change with development 





increased cell populations as well as changes in the ECM. The tumor microenvironment 
is a heterogeneous environment that is most notably characterized by an increase in 
fibroblast and myofibroblast activity, increased angiogenesis, increased infiltration of 
inflammatory cells, and remodeling of the extracellular matrix adjacent to the cancerous 
cell [28]. Without the influence and inclusion of these cell types and structural 
components in current 3D models, it is not possible to completely understand how 
polarity affects tumor initiation, progression, and metastasis. 
Normal human and murine mammary epithelial cell culture models have been 
established to uncover the key components of initiation and maintenance of cell 
differentiation. Those components include both the mammary and stroma cells and the 
proteins of the surrounding ECM [69]. In these models the correlation between cell shape 
and growth and differentiation [45, 46, 66], the role the ECM plays to influence cell 
phenotype [67, 69, 79, 80], and the interaction between epithelial and stromal cells [13, 
25, 81] have been investigated. In most of these 3D culture systems, matrix materials 
(e.g., collagen, reconstituted basement membrane) allow the formation and maintenance 
of morphology and functions mimicking those observed in vivo [69]. In particular, these 
materials support the generation of polarized luminal ductal and acinar structures. 
However, the use of these matrix materials is challenging, in part because of composition 
inconsistency as well as variability between lots, and makes the interpretations of 
observations made in those system more difficult [74]. 
Cancer models have significantly enhanced our understanding of carcinoma 





disruption by cancer genes, the regulation of apical-basal polarity in normal and 
cancerous epithelium, the discovery that cell-cell and cell-ECM adhesion pathways 
interfere with the phenotypic expression during the tumorigenic progression, and the 
emerging importance of ECM tensional force driving 3D tissue architecture and 
homeostasis [74]. While these four areas are of great importance in understanding tumor 
formation and cancer progression, others have also used 3D models to evaluate the 
cytotoxicity and toxicology of cancer drugs [82-84]. While these models help to further 
our understanding of breast cancer and its progression, they have yet to investigate the 
effects of heterogeneity on normal and breast cancer cells.  
Overall, current 3D models have allowed insight into the development and 
function of normal mammary epithelial tissue, tumor formation and cancer progression, 
as well as evaluation of effective therapeutic agents in cancer treatment. However, there 
are limitations as to what cellular and matrix components are used, what these models 
can accomplish, and how well they represent the true in vivo breast conditions. 
Furthermore, standardization of such culture systems may generate a reliable and 
reproducible model to test and monitor breast cancer treatments. Thus, a new modular 3D 
breast tissue model will be developed. The 3D breast tissue model system will be 
customizable to answer specific questions about the normal mammary microenvironment 
and its influence in cancer progression. 
The development of a composite 3D breast tissue model will allow for 
determination of the effects of heterogeneity on normal mammary epithelial and 





with or without beads embedded in the hydrogel, will be evaluated at the macro- and 
micro-mechanical level using an Instron mechanical tester and an atomic force 
microscope (AFM), respectively. MCF10A and MCF7 cell viability, proliferation, and 
function will also be evaluated in these 3D model systems and the effects of stiffness (i.e. 
inclusion of the beads) determined. 
Materials and Methods 
Cell Culture and 3D Breast Model Systems 
Normal breast epithelial cells (MCF10A; ATCC, Manassas, VA) were cultured in 
Dulbecco’s Modified Eagle Medium (DMEM, Atlanta Biologicals®, Lawrenceville, GA) 
supplemented with 10% Fetal Bovine Serum (FBS; Corning, Manassas, VA), 1% 
Fungizone (Life Technologies, Grand Island, NY), 5% antibiotic/antimycotic (Life 
Technologies) and Clonetics® MEGM® SingleQuots® (Lonza, Walkersville, MD) 
supplements including: 2.0 mL BPE, 0.5 mL hEGF, 0.5 mL hydrocortisone, 0.5 mL 
insulin, and 0.5 mL GA-1000. MCF7 cells (ATCC) were cultured in DMEM 
supplemented with 10% FBS, 1% Fungizone, 5% antibiotic/antimycotic. While in 2D 
culture, medium was changed every 2-3 days. Once cells were approximately 75% 
confluent, they were trypsinized (Corning) spun down, and resuspended at 6x106 
cells/mL. To make the 3D breast model systems Collagen Type I (BD Biosciences, 
Bedford, MA) and Matrigel™ (BD Biosciences) at 2.4 mg/mL were used in a ratio of 1:1 
as the stromal component for the 3D models based on previous work by Swamydas et al. 





chamber slides (Nunc, Rochester, NY) and gelled in an incubator (37°C, 5% CO2) for 30 
minutes to provide a base layer in the system. Then a top layer of 300 µL was pipetted 
into a 1.5 mL microcentrifuge tube either without cells (control gels) or with 20 µL of 
MCF10A or MCF7 cell suspension (model gels) and incubated for 24 minutes. The 
microcentrifuge tubes were removed from the incubator and 17 mg of beads were added 
to half of the model gels containing no cells, MCF10A cells, or MCF7 cells. The beads 
were mixed into the gels using 1000 µL pipette tips that were modified to have a wider 
opening, pipetting the beads and gel mixture to mix thoroughly. The model gel contents 
were then transferred to the 8-well chamber slides and plated on top of the base layer. 
Gels were placed in the incubator and respective cell medium added after 24 hours. 
Medium was changed every 3 days. All 3D models were grown for 10 days then 
evaluated for cell viability, acinar- and ductal-like structure formation and measurements, 
and macro- and micro-mechanical changes, as well as histological analysis of cell 
proliferation, cell-cell adhesion, cell-ECM adhesion, and migration markers.  
Live/Dead Assay 
Cell viability was assessed using a LIVE/DEAD® cell viability kit (Invitrogen, 
Eugene, OR) according to the manufacture’s protocol. A Live/Dead assay solution using 
a ratio of 2 mL of Dulbecco’s Phosphate Buffered Saline (PBS; Sigma, St. Louis, MO) to 
1 µL of 4mM calcein AM stock and 4 µL of 2 mM EthD-1 stock was prepared. After a 
30-minute incubation with the Live/Dead assay solution and 10-minute incubation with 





paraformaldehyde (Sigma) for 30 minutes. Gels were rinsed twice with PBS to remove 
any remaining paraformaldehyde. A Zeiss Axiovert 40 (Carl Zeiss MicroImaging, 
Gottingen, Germany) inverted fluorescent microscope was used to capture representative 
fluorescent microphotographs of cells within the 3D constructs. Microphotographs were 
analyzed using Image J (National Institutes of Health). 
Cell Cluster Measurements 
Phase contrast microphotographs of the 3D constructs containing cells were taken 
at the same time as the Live/Dead assay. Microphotographs were captured on a Zeiss 
Axiovert 40 inverted microscope. Using the outline tool in the Zeiss AxioVision software 
(Version 6.4, Carl Zeiss) borders were drawn around the cell clusters and the 
corresponding area of the cell clusters was calculated.  
Macro- and Micro- Mechanical Analysis 
Macro-mechanical analysis of the 3D breast models was conducted using an 
Instron mechanical tester (Instron, Norwood, MA). Acellular model systems were 
produced as stated above in 8-well chamber slides. The chamber slides were then placed 
on a platform (made in house, using acrylic, to fit over the chuck) on the Instron machine. 
A 50 N load cell (Instron) and a circular compression platen (diameter = 6 mm) was used 
to determine how the inclusion of beads within the model changes the mechanical 
properties. The compression platen was lowered into the sample at 3mm/min until the 
Instron registered a compressive load of 0.05 N, indicating full surface contact with the 





mm/min until a strain of 25% was reached based on the average initial thickness of the 
model gels. Bluehill 2 software (Instron) was used to calculate the 3-15% chord modulus 
of the gels. 
Micro-mechanical analysis of the 3D models was conducted using an atomic 
force microscope (AFM). Acellular model systems were produced in a similar fashion 
above, but plated into custom made molds representing an 8-well chamber slide that was 
2 mm thick so that the AFM tip could be lowered into the model systems without 
interference. An MDF-3D-BIO™ AFM (Asylum Research, Santa Barbara, CA) with 
spherical AFM tips (5 mm radii, spring constant 0.08 N/m; NanoandMore, Lady's Island, 
SC) was used. Each sample was tested at four points. The elastic modulus was calculated 
by fitting a Hertz model, as defined in Lance et.al. [162]. 
Histological Analysis 
Histological 3D culture samples were fixed in 4% paraformaldehyde and frozen 
sectioned. Hematoxylin and Eosin (H&E, Richard Allan Scientific, Thermo Fisher 
Scientific, Kalamazoo, MI) staining was used to evaluate the acinar-like and ductal-like 
structure formation within the 3D constructs. A semi-quantitative analysis on a scale of 0-
3 was used to evaluate acinar structure formation with cell clusters containing at least 5 
cells [18] in different construct conditions and concentrations. A semi-quantitative 
analysis on a scale of 0-3 and reported with a score between 0 and 300, with 0 
representing clusters with 2 or fewer cells, 1 representing clusters with 2-5 cells, 2 
representing 5 or more cells with partial polarization, and 3 representing clusters with 5 





acinar structure formation in different construct conditions and concentrations [163]. A 
similar scale was used to evaluate ductal-like structure formation.  
Immunofluorescence was used to determine the expression of E-cadherin (i.e. the 
presence of acinar-like structures and polarization of these cells in the clusters), c-Met 
(migration), Integrinß1 (cell-ECM adhesion), and Ki-67 (cell proliferation). Frozen 
section from 3D cultures for each condition tested were first rehydrated using a series of 
rinses (twice each) in distilled H2O (MilliQ, Darmstadt, Germany), PBS, and 0.2% 
Tween 20 (Bio-Rad, Hercules, CA) in PBS. Then sections were incubated 15 minutes in 
1:1 solution of 5N hydrochloric acid (HCl; Ricca Chemical Company, Arlington, TX) 
and PBS to permeabilize cells. After rinsing twice with 0.02% Tween 20 and then 
blocking using 10% goat serum (Sigma) for 30 minutes, slides were incubated at room 
temperature (RT) for 2 hours with E-cadherin (1:1600 in 1% goat serum, Pierce™ 
Thermo Scientific, Rockford, IL). Following rinsing step, slides were incubated overnight 
at 4°C with Alexafluor® 594-conjugated AffiniPure F(ab’)2 Fragment Goat anti-rat IgG 
(H+L, 1:200; Jackson ImmunoResearch Laboratories, Inc., West Grove, PA). Next, after 
a rinsing step, samples were incubated at RT for 2 hours with either Ki-67 (1:1000, 
Pierce™), c-Met (1:1000, Pierce ™), or Integrinß1 (1:1000, Pierce™). After a 
subsequent rinsing step, slides were incubated overnight at 4°C with. Alexafluor® 488 
goat anti-rabbit IgG (H+L, 1:200; Life Technologies, Eugene, OR). After rinses in PBS 
and ddH20, samples were mounted in ProLong Gold® antifade reagent with DAPI (Life 
Technologies). Slides were allowed to dry and imaged using a Zeiss Axiovert 40 inverted 





quantitatively using the following 0-3 scale with 0 indicating no expression and 3 
indicating positive expression, within cell clusters containing 5 or more cells. Single cells 
and cell clusters containing 4 or fewer cells were excluded from the analysis. Expression 
of Ki-67 and c-Met was evaluated based on expression in single cells. 
Statistical Analysis 
JMP software (SAS Institute Inc., Cary, NC) was used to run a one-way Analysis 
of Variance (ANOVA, α=0.05) to analyze differences comparing all pairs using post-hoc 
Tukey-Kramer HSD for cell viability, cell cluster measurements, mechanical properties, 
and histological analyses. 
Results 
The objective of the study was to investigate whether increased heterogeneity 
generated by the inclusion of polylactide beads in Collagen/Matrigel™ matrices, within 
the 3D models, affected both normal and cancerous mammary epithelial cells. 
Live/Dead Analysis 
In CM matrix containing or not polylactide beads, MCF10A or MCF7 cells were 
seeded and cell viabilities were determined. MCF10A cells showed a significantly higher 
cell viability compared to MCF 7 cells in either CM matrix or CM matrix + polylactide 
beads (p<0.0001, Figure 4.1). In CM matrix, the cell viability of MCF10A cells was 
62.1±20.1%, while the percentage of viable MCF7 cells was 50.1±19.5%. When beads 
were incorporated into the CM matrix, the MCF10A cell viability increased to 





of polylactide beads significantly decreased MCF7 cells viability (p<0.05, Figure 4.1). 
When MCF10A cells were seeded onto CM matrix containing polylactide beads, the cells 
attached and grew on the beads (Figure 4.1B), whereas MCF7 cells in similar conditions 
did not. The coverage of the polylactide beads embedded in the CM matrix by MCF10A 
differed. Nevertheless, MCF10A cells completely coated many of the smaller beads 
(~200-250 µm Figure 4.1B). As most of the beads were lost during the sectioning 







Figure 4.1 (A) Comparison of cell viability in the model systems produced with and without 
polylactide beads; * p<0.05, *** p<0.0001. (B) Fluorescent image of a 3D Hoechst stained 
Collagen/Matrigel™ gel embedded with polylactide beads. Arrow points to a polylactide 
bead surrounded by MCF10A cells; scale bar = 200 µm. (C) Section of an MCF10A model 






Figure 4.2 Phase contrast microphotographs of the model systems containing MCF10A (left 
column) and MCF7 cells (right column) with (bottom row) and without (top row) 
polylactide beads (magnification = 200x, scale bars = 50 µm). In all models without beads, 
single cells and acinar structures formed throughout (black arrows) while ductal-like 
structures (orange arrow) formed mostly in models with MCF10A cells. 
Throughout the different planes of the CM matrix + beads many different 
structures formed. Using phase microscopy, 3D cell structures formed were evaluated. In 
CM matrices throughout the matrix, MCF10A cells were present either as single cells, 
acinar structures, or ductal-like structures (Figure 4.2, upper left). Many of the ductal like 





the gels. In the CM matrix + beads, cells were concentrated mostly in the areas between 
the beads. Consequently, MCF10A cells were densely present in the CM matrix and used 
the beads as a 2D surface proliferating across them (Figure 4.1B). This contrasted with 
MCF7 cells that did not adhere to the beads but rather formed larger cell clusters (Figure 
4.2, lower left). 
Cell Cluster Measurements 
Cell clusters were categorized as single cells/small clusters (0-125 µm2), medium 
sized clusters (126-500 µm2), large clusters (500-2000 µm2), and extra-large clusters 
(>2000 µm2). Seeding of MCF7 cells onto CM matrix embedded with or without beads 
led to the formation of MCF7 cell clusters with surface areas of 1821 and 1442 µm2, 
respectively. In contrast, in similar conditions, MCF10A cell clusters had surface areas of 







Figure 4.3 Percentage of cell clusters that fell within the specified cluster measurement 
ranges of single cells/small clusters (0-125 µm2), medium sized clusters (126-500 µm2), large 
clusters (500-2000 µm2), and extra-large clusters (>2000 µm2).  
Macro- and Micro-mechanical Testing 
Mechanical testing was conducted on acellular model systems with and without 
beads. Instron testing was used to determine if incorporation of polylactide beads 
influenced the macro-mechanical properties of the model systems. No significant 
differences were observed in the mechanical properties of the models when comparing 
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MCF10A w/ Beads, n=93 
MCF10A w/o Beads, n=81 
MCF7 w/ Beads, n=92 





testing the 3% chord modulus of the models was 66.2 ±128.2 Pa (n=12) and 37.3±68.9 Pa 
(n=8) for models without and with beads, respectively. AFM, used to determine the 
micro-mechanical properties of the model systems, indicated that inclusion of beads did 
not affect the micro-mechanical properties of the systems. The modulus was determined 
to be 3.04±0.37 Pa and 2.84±0.99 Pa for the CM matrix without (n=4) and with 
polylactide beads (n=4), respectively. 
Histological Analysis 
MCF10A cells formed acinar and ductal-like structures as shown by H&E 
staining, regardless of the inclusion of beads, within the CM matrix. The number of 
structures formed was semi-quantified. MCF10A cells seeded in CM matrix containing 
beads had the highest acinar structure whereas as MCF10A developed less acinar 
structures when seeded in CM matrix (no beads) (score of 16.5 and 13.1, n≥6). MCF7 
cells in similar conditions led to acinar structure scores of 14.4, and 13.1 (n=6) 
respectively. Ductal-like structure quantification of H&E stained samples also indicated 
that MCF10A cells seeded in CM matrix with beads led to the highest number of duct-
like structure (16.5 vs. 11.7 in CM matrix without beads). MCF7 cells also led to duct-
like structures more so in CM matrix containing beads (12.6 vs. 9.7, respectively). While 
these observations have a high variability (no significant differences was observed 
between cells or conditions for score for acinar and ductal structures), the inclusion of 






Furthermore, the expression of Ki-67, E-cadherin, Integrinß1, and c-Met were 
investigated to assess cell proliferation, cell-cell attachment, cell-ECM attachment, and 
migration. The number of Ki-67 positive cells a marker of cell proliferation, was between 
0.9 and 1.9% regardless of cell or condition tested. More proliferation was observed with 
MCF10A cells (1.9% and 1.7% for CM matrix with and without beads, respectively) 
compared to MCF7 cells in similar conditions (1.4% and 0.9% in CM matrix with and 
without beads, respectively). E-cadherin was analyzed in cell clusters containing 5 or 
more cells. CM matrix containing beads led to higher E-cadherin expression, 107 and 83 
for MCF10A and MCF7 cells, respectively. In CM matrix (no beads) E-cadherin 
expression was lower (81 and 71 for MCF10A and MCF7 cells, respectively). No 
significant difference was observed between the conditions tested regardless of the 
embedding of beads or the cells tested. Nevertheless, these observations strongly suggest 
that increasing the heterogeneity of the CM matrix by the addition of polylactide beads 
promote acinar structure formation especially by MCF10A cells. The expression of 







Figure 4.4 E-cadherin staining of model systems. First column includes nuclei stained using 
DAPI. Second column, same sections stained with E-cadherin primary antibody. Third 
column, combined images overlaying the DAPI stained nuclei and the E-cadherin images. 






Criteria for to a optimized breast tissue 3D model included the ability to easily 
and quickly change the stromal components to mimic different stages in breast 
development and breast cancer progression. Further, knowing that the breast cancer 
environment is heterogeneous, different materials and/or cell types were incorporated 
within the 3D model. The rationale associated with the incorporation of polylactide 
microspheres in the 3D model was two-fold. First, the polylactide beads are much stiffer 
[164] compared to the hydrogel stromal components composed of Collagen Type-
I/Matrigel™ [162], Second, as the beads degrade they release lactic acid into the 
surrounding microenvironment helping mimic an acidic microenvironment normal in 
breast cancer. While lactic acid release was not a parameter studied in the present set of 
experiments designed to develop an heterogeneous 3D environment, lactic acid release 
profiles likely would be similar to that presented in Chapter 2. The latter demonstrates 
that polylactide beads can be used in multiple facets to study different effects.  
During the formation of the 3D matrix, a bi-layer approach was used to prevent 
the polylactide beads from settling out of the gels to the bottom of the wells. To get the 
beads to stay suspended throughout the top layer of the constructs, the 
Collagen/Matrigel™ components were incubated for 24 minutes and then beads were 
mixed into the pre-gelled matrix. Since the gels were “pre-gelled” prior to adding the 
beads, when the beads were mixed in the gel separated into chucks. After the beads are 
mixed in, the chunks of pre-gelled components intermix within the non-gelled 





keeping them suspended within our top layer. This method of mixing the beads into the 
gel needs to be optimized further as differences in incubators and mixing methods 
influence how well the pre-gelled phase keeps the beads in suspension. 
In 3D CM matrix embedded with beads, the MCF10A cells are close enough to 
the beads to sense the increased stiffness leading to cell migration and attachment to the 
beads. In contrast, MCF7 cells did not attach to the beads in similar conditions. This is 
most likely due to the anchorage dependence of MCF10A a behavior that is decreased or 
lost in MCF7 cells.  
Cell viability and cell cluster were used to ensure that the CM derived constructs 
generated consistently mimicked observed made earlier  (see Chapter 3). Inclusion of the 
beads in the CM matrix did not seem to affect the cell viability. In fact an increased the 
MCF10A cell viability as the beads provided additional surface for cells to adhere and 
proliferate. Further, cell cluster observations made in the CM matrices embedded with 
polylactide indicated that the pre-gelling process did not affect cell viability or how cells 
clustered together. However, the double mixing step may have promoted the migration of 
cells out of the CM matrix resulting in fewer clusters of cells as compared to our previous 
observations where the top layer was plated and gelled without the intermediate “pre-
gelling” step before adding beads (See Chapter 3).  
 Mechanical testing of the CM matrix with or without embedded polylactide 
beads was conducted. However, due to the properties of the CM matrices, they could not 
be removed from their plastic wells for mechanical testing. Thus, the CM matrices with 





beads cut through the CM matrix due to the stiffness differential between the beads and 
CM matrix and the pockets of liquid within the gels. To improve the accuracy of 
measurements of the stiffness, an improved method of generating the CM matrix ± beads 
should be implemented. The steps associated with the generation of CM matrix ± beads 
also limited micro-mechanical testing methods. Normally when conducting AFM, gels 
are tested in an unconfined manner, but due to the properties of the gels only confined 
tests could be run. Further, the beads used in the CM matrix were on average 300 µm in 
diameter, so the CM matrix had to be at least 500 µm thick to ensure that the beads were 
suspended in the matrix. At this thickness, it was not possible to image through the 
matrix while taking measurements. This made it impossible to determine exactly where 
measurements were being taking within the matrix. To make more definitive conclusions 
about how the incorporation of the beads affected the stiffness of the microenvironment 
detected by the cells, more measurements at specific locations within the 3D 
microenvironment should be undertaken.  
The formation of cell clusters within the 3D conditions tested either acinus- or 
duct-like structures was demonstrated using H&E staining and DAPI nuclear staining 
MCF10A cells in the 3D condition tested formed cell clusters and cell clusters with 5 or 
more cells started to form a polarized structure with hollow center. In contrast, when 
MCF7 cells were cultured in those 3D conditions clustered cells rarely formed polarized 
structures. Indeed, some of the MCF7 cell clusters had over 20 cells but no organized 
structure. Further, MCF10A cells cultured in 3D CM matrix with beads led to clustered 





structures. While E-cadherin expression as seen in MCF7 cell clusters generated in 
similar 3D culture conditions, the expression was not as localized between the cells 
contrasting with the observation made in MCF10A cell clusters.  
The embedding of beads to increase matrix heterogeneity led to increased cell 
density in the matrix areas between the beads. These increased cell densities were 
associated with the formation of larger clusters. This could be in part due to increased 
signaling between cells through increased growth factor concentrations and/or direct cell-
to-cell contacts. Additionally, this could also be explained in part by the variation in the 
mechano-transduction generated within the 3D CM matrix by the addition of beads. 
Indeed, beads have a higher mechanical stiffness compared to Collagen and Matrigel™ 
and, thus the cells may be responding to this localized stiffness increase. Further research 
should be conducted to confirm the importance of mechano-transduction in the cell 
behavior.  
Summary 
A tunable 3D breast tissue model was generated that incorporate polylactide 
beads to assess the effects of matrix heterogeneity on the behavior of both normal 
mammary epithelial and cancerous epithelial cells. Further work should focus on refining 
the process in which beads are suspended in the Collagen/Matrigel™ matrix and on the 
optimization of the number of cells to be seeded in the 3D model. Additional validation 
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The increasingly technical global economy and rapidly changing national 
demographics have presented the US with a critical workforce shortage in the educational 
areas of Science, Technology, Engineering, and Mathematics (STEM) [165]. As the 
country attempts to maintain its leadership position in research, development, and 
innovation, studies reported in the literature have made clear that US production of 
STEM graduates needs improvement. Employment in STEM fields grew by 23% 
between 1994 and 2003, compared to only 17% for non-STEM fields; nonetheless, the 
US is now struggling to meet the rapidly increasing demand for STEM workers [166]. 
The continued need to remain globally competitive and the fact that 39% of people in the 





colleges and universities to improve their efforts to graduate minority students in STEM 
disciplines [167].  
Along with an increased interest in undergraduate degree attainment, there is 
significant interest in increasing the number of graduate degrees awarded in STEM, 
particularly to underrepresented minority students [168]. STEM education researchers 
have commonly defined underrepresented minorities (URMs) as African American, 
Hispanic/Latino, or Native people, including Native American, Alaska Native, Native 
Hawaiian, and Pacific Island individuals [168]. The drive to increase the number of 
graduate degree recipients is directly relevant to research and innovation goals and 
national economic interest [168]. One of the strategies employed for increasing the 
number of URM students in STEM has been the introduction and promotion of 
undergraduate research programs. Both federal and private agencies have committed to 
investing significant funding into these programs, as they have been reported to increase 
student intention of enrolling in graduate or professional schools [169, 170]. The National 
Science Foundation (NSF), through the Emerging Frontiers in Research and Innovation 
(EFRI) program is one of these program examples. The NSF has awarded supplemental 
funding for Research Experience and Mentoring (EFRI-REM) outreach programs with a 
focus on developing research in STEM disciplines. The REM program provides a 
training program for researchers and supports the national priority to attract and retain a 
diverse STEM population. 
Many researchers have explored potential causes for minority student 





stereotype threats, familial or societal expectations, or low esteem have been presented as 
potential reasons for low interest, aspiration, admission, retention, and persistence in 
STEM of ethnic minority students [171-178]. Diminished pursuit of graduate studies for 
URM students were thought to be largely related to financial hardship post baccalaureate; 
however, further research has shown that URMs in STEM also may not see graduate or 
professional schools as significantly beneficial to career aspirations and interest [179]. 
Undergraduate research programs have been shown to be effective in fostering the 
interest, skills, and aspirations that may develop into pursuit of graduate / professional 
school and potential research and innovation careers [169, 170]. The concept of 
“communities of practice” described by Wenger supports the idea that participation in 
different communities and experiences affects participant identity development [180]. 
The National Science Board members, in their report “Moving Forward to Improve 
Engineering Education”, propose participation in research experiences, specifically in the 
freshman and sophomore years, as a desirable means to engage URM students in the 
community of STEM [181]. These experiences aim at introducing students to STEM and 
broadening their education while improving retention. One aspect that has been 
highlighted by undergraduate research experts is identity development within the context 
of STEM [169]. Attention to identity has increased, specifically within the sciences 
[182], as work continues toward increasing the STEM population and workforce. 
Investigators have suggested that participation in an undergraduate research program 
results in domain identity related to the area of participation [183]. It is this identity 





of a research identity integrated with a student’s STEM domain-specific identity. 
Domain-specific identity, comprising three dimensions of student beliefs - interest, 
performance/competence, and recognition, has been used to observe math, physics, and 
general sciences identities [184-189].  
It has been suggested that engineering research is advanced by an increasingly 
diverse population of STEM researchers aiming to complete interdisciplinary research 
objectives. Diversity of thought and perspective is a prerequisite to addressing the 
world’s complex problems. There is a significant need for training and development of 
diverse populations to answer evolving research questions. To develop researchers one 
must understand how their identity, which is based on a researcher’s belief about his/her 
performance, competence, recognition by others, and interest, influences their feelings of 
preparedness for research experiences. It is our assertion that students that feel more 
prepared for research experiences are more likely to participate in future research 
experiences.  
Our study focused specifically on a research training opportunity funded by the 
National Science Foundation (NSF) Emerging Frontiers in Research and Innovation 
(EFRI) program. We hosted an undergraduate research program to introduce 
underrepresented, early-stage undergraduates to research using our tissue-engineering 
laboratory as the backdrop. The program was designed as a first step toward full 
engagement in undergraduate research, i.e., to lower the perceptual barriers to 
participation, provide tools, and promote confidence to pursue rigorous research. We 





engineering research experience prepared the students for future research endeavors in 
their own majors. Student experiences highlighted in this study pertain to their 
participation in an NSF-EFRI Research Experience and Mentoring (REM) program 
during the academic year and subsequent research or professional experiences the 
following summer. These research or professional experiences included Research 
Experience for Undergraduates (REU) programs, cooperative education (co-op) 
experiences, institutionally-funded research programs, and other summer employment 
opportunities. The purpose of this study was to understand how a student’s perception of 
preparedness is influenced by the student’s science and engineering identity, based on 
their participation in interdisciplinary research. 
Methods 
Clemson University (CU) and the University of North Carolina at Charlotte 
(UNCC) receive NSF:EFRI funds that allow CU engineering researchers and UNCC 
biology researchers to work together to build and analyze breast cancer benchtop tissue 
test systems. The NSF distributed a competitive call for supplemental funding proposals 
to funded EFRI grantees, termed Research Experience and Mentoring; the goal of the 
opportunity was to further the progress in EFRI topic areas while broadening 
participation of underrepresented groups in STEM fields [190]. CU and UNCC 
successfully competed and were awarded REM funding for the 2012-2013 academic 
year. The objective of the CU-UNCC NSF:EFRI-REM program was to introduce URM 
undergraduate students, especially those at an early transition point in their academic 





create credentials for future research opportunities. Students with no prior research 
experience were specifically recruited.  Each student participated in 1 semester of the 
NSF:EFRI-REM program, either in the fall or spring, and each had the opportunity to 
apply to participate in a 10-week REU program encompassing experiences at both 
universities. All REM participants were encouraged to apply for other REU programs 
across the nation, other summer research experiences, or co-operative education 
experiences. 
During the school year, URM students were recruited through CU and UNCC-
supported offices with focus on underrepresented student recruitment and retention in 
STEM. Students were encouraged to apply for the REM opportunities and were selected 
based on their interest in the program, their ability to communicate how this experience 
might influence them, and their academic progress (including performance in STEM 
classes). The principal investigators, graduate student and staff mentors reviewed 
applications, and the undergraduate students, termed by NSF the Research Participants 
(RPs), were invited to participate in the REM program. Each semester, the REM program 
began with a Research Studio lasting approximately 8 hours before students began the 
laboratory experience. The Research Studio began with a pre-survey regarding research 
experiences and then included an introduction of tissue test systems and overall EFRI 
project goals, completion of laboratory safety training, an introduction to research ethics, 
technical writing, and basic laboratory practices, participation in a team building exercise, 
discussion of the projects to which each student would be exposed, and discussion of the 





paired with a graduate student mentor and the mentor’s project. After completion of the 
Research Studio, each student was required to spend 3 hours on lab/research-related 
activities each week during the semester. Weekly professional development exercises 
introduced the RPs to a variety of research-related skills and topics. Students ended the 
semester with a rapid fire podium presentation and poster presentation at Networking 
Day, a day where all students, graduate student mentors, faculty mentors, and external 
support mentors gathered to discuss research activities and outcomes of the REM 
program. A research experience post-survey was given, following the 15-week semester, 
to assess the student experience.  
The joint EFRI:REU began in late May for a 10-week period and included two 
RPs from CU and two RPs from UNCC. The first 5 weeks were spent in the engineering 
laboratories at Clemson University, and the second 5 weeks in cancer biology 
laboratories at the University of North Carolina at Charlotte. Each REU weekday 
consisted of approximately 8 hours of lab/research-related activities. All EFRI:REU RPs 
gave poster presentations overviewing their research at the end of the REU and all 
EFRI:REU students were invited to apply to participate in/present at the NSF and 
American Association for the Advancement of Science-sponsored Emerging Researchers 
National Conference in STEM in Spring 2014. 
Each academic semester, eight RPs participated in the REM program, four at each 
university. The demographics of the population were determined by information 
submitted in the REM applications, including gender, ethnicity, college level, major (with 





thirteen female. Students self-indicated their ethnicity on the application as: Hispanic or 
Latino (regardless of race), American Indian or Alaska Native, Asian American, Black or 
African American, White, or Native Hawaiian or Other Pacific Islander. The population 
included two Hispanic or Latino students, thirteen Black or African American students, 
and one Asian American student. RPs included thirteen sophomores, one freshman, and 
two juniors. Clemson University RPs were students seeking either engineering or science 
degrees while University of North Carolina at Charlotte RPs were students pursuing 
science degrees. Out of the 16 participants, six were obtaining engineering degrees in 
industrial engineering, computer engineering, environmental engineering, and chemical 
engineering, while two had yet to declare an area of focus and were still in the general 
engineering program. The other 10 students were pursuing science degrees; specifically, 
chemistry (1) and biology (9). Of the 16 students that participated in the REM program, 
two from each university were selected to participate in the summer REU program. All of 
the REU participants were female and three of the four were science majors. The REU 
RPs, all females, identified their ethnicities as Asian American (1), Hispanic/Latino (1), 
and Black or African American (2).  
The REM program pre- and post-survey (Table 5.1) was administered to CU 
students only and was used to assess how the REM program influenced students’ feelings 
of preparedness for future research programs and to assess skills gained through the 
program. Pre- and post-surveys included: participant demographics (i.e. name, 
educational aspirations, major), research preparedness items (Q1-Q5, Table 5.1), research 





laboratory practices and attributes. Items Q1-Q5 were evaluated on a Likert-type scale, 
with 1 indicating strong disagreement and 5 indicating strong agreement. Questions Q6-
Q10 were answered as yes/no and evaluated in binary format, where yes = 1, no = 0. An 
Analysis of Variance (α=0.05) was used to analyze pre- to post- response as a whole as 
well as with respect to academic term. 
 
Table 5.1 Pre- and Post-Preparedness Survey Items  
Research Survey Items 
Item # Research Preparedness Items 
Q1 I feel prepared to participate in a research program at the college level 
Q2 Research is an important part of my undergraduate education 
Q3 Continuing research as a graduate student would be beneficial to me and my career goals 
Q4 I feel comfortable speaking about or presenting scientific research in an academic setting 
Q5 I am familiar with ways to find research opportunities 
 Research Skills Assessment Items 
Q6 Have you ever applied to participate in a research program at the college level (other than to this program)? 
Q7 Have you ever participated in a research program at the college level? 
Q8 Have you ever used scientific journals as part of a research project? 
Q9 Have you ever given a research presentation (oral or poster)? 
Q10 Have you ever attended or participated in a research conference or meeting? 
 
An identity survey, given to REM participants from both CU and UNCC, was 
used in order to assess identity development after participation in the REM program. 
Former REM RPs were given an identity pre-survey in May before they started their 
summer activities. Eleven of the 16 participants completed the pre-survey. Students that 
completed the pre-survey were given a follow-up identity post-survey the first week of 
the fall semester following the various summer activities. Ten post-surveys were 





experiences of these 10 RPs included REU (4), co-operative education experience (2), 
summer research experience (2), and non-research related activities (2). The identity 
survey questions were adapted from the Sustainability and Gender in Engineering (SaGE) 
survey [184-186, 188, 189]. Questions for engineering and research identity were adapted 
from these valid and reliable survey items with the help of experts in engineering 
education research. The survey items were divided into three identities; science, 
engineering, and scientific research. The same questions were asked to investigate each 
identity, substituting the word science, engineering, or scientific research in each item. 
Each question was evaluated on a Likert-type scale, the far left of the scale anchored as 
“Strongly Disagree” (1.0) and the far right of the scale anchored as “Strongly Agree” 
(7.0). Questions in the survey pertaining to preparation were categorized based on the 
type of future experience, and included research, non-research, and graduate research 
questions. Statistical analysis of the data was conducted using Analysis of Variance 
(ANOVA, α=0.05) to determine statistical differences between majors, for both pre-
survey and post-survey responses, and within majors (pre- to post-response). 
Results and Discussion 
REM Program Survey 
The REM survey results indicated an overall positive increase in student survey 
responses pertaining to preparedness in research and its influence on future research 
activities. The results suggest the students felt more prepared to participate in research and 





completing research activities. Significant increases were seen in two of the responses 
from pre- to post-survey, specifically “I feel prepared to participate in a research program 
at the college level” and “I am familiar with ways to find research opportunities” (Figure 
5.1A), with p-values of 0.0172 and 0.0075, respectively. Further, a significant increase 
(p=0.0089, Figure 5.1B) was seen in response to the question “Have you ever used 
scientific journals as part of a research project”. 
 
 
Figure 5.1. REM research program survey results. Asterisk indicates significant differences 
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The NSF:EFRI–REM program resulted in a significant increase in students’ 
feeling of preparation for future research experiences. By introducing students early in 
their career to research activities, we begin to give them the tools necessary to succeed in 
future research endeavors. Teaching skills that will be used in both academic and research 
settings allows students to gain confidence in themselves and their abilities to succeed in 
similar situations, thus preparing them for STEM careers. 
Identity Survey  
Results from pre- and post- identity surveys suggest that science and engineering 
identities are related to each other, as well as to the development of research identity. The 
analyses shown below in Tables 5.2, 5.3, and 5.4 compare survey item responses for 
science majors versus those of engineering majors. For example, the first line of Table 
5.2 indicates that pre-survey responses for science majors yielded a mean (µ) response of 
6.80, while engineering majors had a mean response of 7.0. These responses were related 
to the question, “To what extent do you disagree or agree with the following statement? I 
am interested in learning more about science.” The difference in science majors’ and 
engineering majors’ pre-responses yielded a non-significant p-value of 0.3466 after 
ANOVA testing. Similarly, post-responses also had a non-significant difference 
(p=0.1720) with means of 7.0 and 6.4 for science and engineering, respectively. Analyses 
completed comparing pre- to post-responses within majors were conducted but are not 
included in table format. Only two of the survey items were significant; descriptions of 






Table 5.2: Self-Reported Interest Items Comparing Science and Engineering Majors. 
Symbols µ and σ represent the mean and standard deviation of the population, respectively. 
P-Values highlighted indicate significant differences between majors. 
  





Survey Item Μ σ µ Σ µ σ µ σ 
To what extent do you disagree or agree with the following statements? 
I am interested in learning more 
about science 6.80 0.45 7.00 0.00 0.3466 7.00 0.00 6.40 0.89 0.1720 
I enjoy learning science 7.00 0.00 6.60 0.55 0.1411 6.80 0.45 6.60 0.55 0.5447 
To what extent do you disagree or agree with the following statements? 
I am interested in learning more 
about engineering 5.00 1.73 7.00 0.00 0.0325 5.20 1.64 6.80 0.45 0.0688 
I enjoy learning engineering 4.40 0.89 6.80 0.45 0.0007 5.20 0.84 6.80 0.45 0.0055 
To what extent do you disagree or agree with the following statements? 
I am interested in learning more 
about scientific research 6.60 0.55 6.40 0.89 0.6811 6.75 0.50 6.40 0.89 0.5097 
I enjoy learning scientific 
research 6.60 0.55 6.40 0.89 0.6811 6.60 0.55 6.40 0.89 0.6811 
 
Two questions addressed the aspect of domain-specific interest. The questions “I 
am more interested in learning more about …” and “I enjoy learning …” revealed 
significant differences between the science and engineering majors when the topic was 
engineering, for both the pre-survey and post-survey responses (Table 5.2). While the 
science and engineering majors’ means for both the pre-survey and post-survey are nearly 
equal for science and scientific research identity items, the engineering identity items 
reveal a significant difference. Engineering students identified much more interest in 
engineering topics as compared to the science students. 
Questions were posed about RP competence in the three areas of science, 





was not included in this analysis as there were no grades assigned to student research 
outcomes. Regarding competence (Table 5.3), it was found that science students felt 
significantly less confident in their ability to understand science outside the classroom 
after their summer experience. This could be, in part, because more in-depth research and 
summer experiences broadened the students’ perspectives to what is required to 
understand science and conduct scientific endeavors outside the classroom.  
The other area of significance of note within competence from Table 5.3 is in the 
differences of “understanding engineering”, “understanding concepts studied in 
engineering”, and “being able to overcome limitations and setback/obstacles in 
engineering”. Significant differences were seen by science students in all of these 
categories except “I am confident that I can understand engineering in the laboratory”. 
The results may be explained, in part, by the fact that three of the five science majors 
who completed the surveys participated in the joint summer EFRI:REU program. The 
summer EFRI:REU incorporated an engineering component and thus many of the science 
majors were exposed to engineering problems. The engineering students were 
significantly more confident in every one of these categories after their summer 
experiences. This result was expected, as all but one of the engineering RPs that 
completed the survey were involved in summer research that focused on some aspect of 
engineering, most of them in areas of their own majors. These RPs gained experience and 
knowledge in their specific engineering areas and thus would have strengthened identity 
in the area of competence. The engineering question that did not result in significant 





“Engineering makes me nervous”. However, the science students, when comparing their 
pre- to post-summer experience responses with respect to science, did indicate 
significantly less (p = 0.0046, data not shown in table format) nervousness post-summer. 
One of the major foci for this study was the development of feelings of 
preparedness for future research opportunities. Results shown in Table 5.3 below indicate 
that both engineering and science majors are relatively confident in their level of 
preparedness for future research. This is signified by means above 6.0 for nearly every 
preparedness item. There was no significant difference between engineering and science 
majors in terms of preparedness, suggesting the program helped to develop confidence in 
research preparedness across the spectrum of represented majors. The mean confidence 
level of science majors with respect to preparedness items was also slightly higher 
(though not significant), again indicating that perceived research outcomes may be more 













Table 5.3: Self-Reported Competence Items Comparing Science and Engineering Majors. 
Symbols µ and σ represent the mean and standard deviation of the population, respectively. 
P-Values highlighted indicate significant differences between majors. 
 





Survey Item Μ σ µ σ µ σ µ σ 
To what extent do you disagree or agree with the following statements? 
I am confident that I can 
understand science in class 6.40 0.55 6.20 0.84 0.6666 6.80 0.45 6.80 0.45 1.0000 
I am confident that I can 
understand science in the 
laboratory 
6.20 0.45 6.20 0.84 1.0000 6.60 0.55 6.20 1.10 0.4860 
I am confident that I can 
understand science outside of 
class 
6.40 0.55 5.20 0.84 0.0278 6.60 0.55 6.40 0.89 0.6811 
I understand concepts I have 
studied in science 6.60 0.55 5.80 0.84 0.1114 6.80 0.45 6.60 0.55 0.5447 
Science makes me nervous 4.20 1.79 3.20 2.28 0.4626 3.20 1.48 3.40 2.07 0.8651 
I can overcome limitations in 
science 5.60 0.89 5.75 1.50 0.8565 6.20 0.84 6.40 0.55 0.6666 
I can overcome 
setbacks/obstacles in science 5.60 0.89 6.00 1.00 0.5237 6.40 0.55 6.40 0.55 1.0000 
To what extent do you disagree or agree with the following statements? 
I am confident that I can 
understand engineering in class 4.40 0.55 6.40 0.55 0.0004 4.80 1.48 6.40 0.89 0.0727 
I am confident that I can 
understand engineering in the 
laboratory 
5.20 1.30 6.40 0.55 0.0943 5.20 1.64 6.00 1.00 0.3796 
I am confident that I can 
understand engineering outside 
of class 
4.40 0.89 6.00 0.00 0.0039 4.60 1.52 6.40 0.89 0.0516 
I understand concepts I have 
studied in engineering 4.40 0.89 6.40 0.55 0.0027 4.40 1.82 6.20 0.84 0.0790 
Engineering makes me nervous 4.60 0.89 3.60 2.30 0.3917 3.00 1.22 3.00 1.41 1.0000 
I can overcome limitations in 
engineering 4.00 0.71 6.00 1.00 0.0065 4.20 0.45 6.40 0.55 0.0001 
I can overcome 
setbacks/obstacles in 
engineering 
4.00 0.71 6.20 1.10 0.0054 4.60 0.89 6.40 0.55 0.0050 
To what extent do you disagree or agree with the following statements? 
I am confident that I can 
understand scientific research in 
class 





I am confident that I can 
understand scientific research in 
the laboratory 
6.40 0.55 6.00 0.00 0.1411 6.60 0.55 6.20 0.84 0.3972 
I am confident that I can 
understand scientific research 
outside of class 
6.00 0.71 5.60 0.55 0.3466 6.40 0.55 6.00 1.00 0.4554 
I understand concepts I have 
studied in scientific research 6.20 0.45 5.80 1.10 0.4714 6.60 0.55 5.80 0.84 0.1114 
Scientific research makes me 
nervous 4.80 1.30 4.00 2.00 0.4751 3.40 1.52 3.40 1.82 1.0000 
I can overcome limitations in 
scientific research 5.80 0.45 6.00 1.22 0.7404 6.20 0.84 6.40 0.55 0.6666 
I can overcome 
setbacks/obstacles in scientific 
research 
5.80 0.45 6.40 0.55 0.0943 6.40 0.55 6.40 0.55 1.0000 
To what extent do you disagree or agree with the following statements? I feel prepared to participate in... 
Academic research program 
(e.g. REU, research experience) 
offered during the summer 
6.40 0.55 6.00 0.71 0.3466 6.80 0.45 6.40 0.89 0.3972 
Academic research programs 
offered during the academic 
year 
6.40 0.55 6.20 0.45 0.5447 6.80 0.45 6.60 0.55 0.5447 
Non-academic research 
program (e.g. scientific or 
engineering based co-operative 
education experience or 
internship) offered during the 
summer 
6.20 0.45 6.40 0.55 0.5447 6.60 0.55 6.40 0.89 0.6811 
Non-academic research 
programs offered during the 
academic year 
6.20 0.45 6.20 0.45 1.0000 6.40 0.55 6.20 0.84 0.6666 
Continued research at the 
graduate level 6.40 0.55 5.75 0.96 0.2381 6.40 0.55 5.80 1.10 0.3052 
 
The third aspect of identity, recognition, reveals some of the stark differences 
between science students and engineering students with respect to how they and others 
recognize them in the communities of practice of science, engineering, and research. 
Recognition plays a crucial role in how people see themselves fitting into a Community 
of Practice and a lack of recognition has been shown to deter students from pursuing 





Before the summer experience, science students reported significantly higher 
(p=0.0039) recognition from their mentor(s) as compared to engineering students, 
whereas in every other aspect of science identity (i.e. recognition of self and recognition 
by parents, friends, advisor(s), and faculty), there were no significant differences by 
major in either the pre- or post-summer experience items. Engineering identity of science 
majors was significantly lower (Table 5.4) compared to the engineering majors both pre- 
and post-summer experience, except for recognition by their mentor(s) in the pre-survey. 
The higher recognition by mentor(s) of the science students in this category could be due 
to the fact that two of the five science students who completed the surveys participated in 
the engineering REM program instead of the science REM program, thus their mentor(s) 
were of engineering backgrounds instead of biology. The last significant difference of 
note was between majors evaluating the survey item “Others ask me for help in scientific 
research”. The science student responses, in the pre-survey, reveal significantly higher 
(p=0.0438) recognition with respect to others asking their help compared to engineering 
majors. This difference is most likely influenced by the coursework completed by each 
student. Many of the engineering students, at this point in their degree progress, have just 
begun to enroll in science-related classes, whereas science degree-seeking students 
enrolled in general science classes immediately upon matriculation as they are required to 
take many more science classes compared to engineering students. Further, engineering 
students are less likely to take a biology class compared to science students, as most 
engineering degrees require many more physics classes and physics is not, at this point, 





Table 5.4: Self-Reported Recognition Items Comparing Science and Engineering Majors. 
Symbols µ and σ represent the mean and standard deviation of the population, respectively. 
P-Values highlighted indicate significant differences between majors. 
 





Survey Item Μ σ µ σ µ σ µ σ 
To what extent do you disagree or agree with the following statements? 
I see myself as a science 
person 6.60 0.55 5.80 1.10 0.1823 7.00 0.00 5.60 2.19 0.1909 
My parents see me as a science 
person 6.60 0.55 5.80 1.64 0.3319 6.80 0.45 5.60 2.07 0.2415 
My friends see me as a science 
person 6.80 0.45 5.40 1.34 0.0578 7.00 0.00 5.40 2.07 0.1228 
My faculty advisor sees me as a 
science person 6.20 1.30 5.40 0.89 0.2907 6.80 0.45 4.75 2.06 0.0641 
My mentor(s) see me as a 
science person 6.60 0.55 5.00 0.71 0.0039 6.80 0.45 5.40 2.07 0.1783 
My professor(s) see me as a 
science person 6.00 1.22 4.80 0.45 0.0736 7.00 0.00 5.20 2.05 0.0851 
Others ask me for help in 
science 6.00 0.71 5.20 1.48 0.3080 6.40 0.89 6.40 0.89 1.0000 
To what extent do you disagree or agree with the following statements? 
I see myself as an engineering 
person 3.80 1.64 6.60 0.55 0.0068 4.20 1.64 6.60 0.55 0.0147 
My parents see me as an 
engineering person 2.80 1.10 6.40 0.55 0.0002 3.80 1.30 6.40 0.55 0.0034 
My friends see me as an 
engineering person 2.75 1.50 6.20 0.84 0.0031 3.60 1.52 6.40 0.55 0.0047 
My faculty advisor sees me as 
an engineering person 2.40 1.14 5.80 0.45 0.0003 3.40 1.34 6.40 0.55 0.0017 
My mentor(s) see me as an 
engineering person 3.80 2.17 5.80 0.45 0.078 4.00 1.58 6.40 0.55 0.0125 
My professor(s) see me as an 
engineering person 3.20 1.64 5.40 0.55 0.0218 3.40 1.34 6.20 0.84 0.0042 
Others ask me for help in 
engineering 3.00 1.22 6.00 1.00 0.0028 2.20 1.30 5.80 1.64 0.005 
To what extent do you disagree or agree with the following statements? 
I see myself as a scientific 
research person 5.80 0.45 5.40 1.52 0.5871 6.60 0.55 5.20 2.05 0.1783 
My parents see me as a 
scientific research person 6.20 0.45 5.20 1.48 0.1869 6.00 0.71 5.40 1.95 0.5358 
My friends see me as a 





My faculty advisor sees me as a 
scientific research person 6.00 0.00 5.20 1.30 0.2073 6.20 0.45 5.00 2.12 0.2509 
My mentor(s) see me as a 
scientific research person 6.20 0.45 5.20 1.30 0.1434 6.60 0.55 5.20 2.05 0.1783 
My professor(s) see me as a 
scientific researcher 5.80 0.45 4.80 1.30 0.1434 5.80 1.30 5.40 2.07 0.7245 
Others ask me for help in 
scientific research 5.00 1.00 3.00 1.58 0.0438 5.60 0.55 5.00 1.87 0.5108 
 
One of the major outcomes of this analysis was the indication that science RPs did 
not identify as engineers, either before or after participation in various summer 
experiences. This result was consistent across all explored aspects of identity: interest, 
competence, and recognition. This result was also statistically significant across most 
survey items concerning engineering identity, with science RPs reporting statistically 
lower means than those of their engineering RP counterparts. For the RPs surveyed, this 
result suggests a distinction between science and engineering for students majoring in 
science. When comparing science major responses with regard to science identity to 
corresponding engineering identity items, a significantly higher mean response (statistics 
not shown in table) can be seen for science responses. This further supports the assertion 
that these science RPs have very strong viewpoints on the components of science identity 
and its distinction from engineering identity components. 
In contrast to these results, engineering RPs indicated comparable levels of 
science identity as reported by their science RP colleagues. It can be seen across each 
measured component of identity that engineering student and science student responses to 
science-focused identity items resulted in non-significant differences in most cases. It is 
our assertion that these results indicate an intersectionality of science identity and 





study as inherently different as do the science students. This idea is supported by the 
work of Godwin and coworkers, in which both science and physics identities were shown 
to support or contribute to the development of engineering identity [186]. These results 
suggest that for these engineering students, the components contributing to a strong 
science identity are the same as, or necessary for the development of, the components of 
their engineering identities. 
These contrasting results are interesting, considering the implications derived 
from the research identity items explored in this study. For the most part, research 
identity items yielded non-significant differences between science and engineering 
majors for both pre- and post-survey results. However, closer examination of the mean 
values of these items reveal that, although not significant, science majors consistently 
reported slightly higher responses than engineering majors with respect to research 
identity items. Because these results are not statistically significant and because of the 
limited sample size, one cannot definitively conclude science majors report higher 
research identity than engineering majors. However, the consistency of the responses 
across all areas of identity suggests that science identity may be more closely linked to 
research identity for these students. Interestingly, the lack of significant difference also 
suggests that engineering students also readily identify with components of research. Two 
explanations may clarify this result. First, engineering students may identify with 
research through some set of components common to both engineering and science 
identity. This explanation supports the previous assertion there is significant 





Second, engineering students may identify with research through their identification with 
science. This idea supports the previous statement that the most direct link to research 
identity may be through a strong science identity, but science and engineering identities 
are indeed separate. Figure 5.2 below illustrates these two potential explanations. 
 
 
Figure 5.2 Potential explanations for research identity data. 1) Significant intersectionality 
between engineering and science identities, with science identity being most directly linked 
to research identity. 2) Engineering and science identity are distinctly different, but 
connected. Science identity is most directly linked to research identity. 
It is also important to note some outcomes of this work not specifically related to 
the analysis. Science student post-survey results indicated a significantly higher response 
to the item, “I see myself as a research person” when compared to pre-survey results. 
This result indicates a significant growth in the self-recognition component of research 
identity for this group of students. It was the goal of this work to improve research 
identity development in these students; therefore, this result was a positive outcome of 





pre- and post-results without a statistically significant difference. This result reinforces 
the previous assertion that students of both majors more closely associate research with 
science at this stage in their academic development. It is our hypothesis that the differing 
natures of summer experiences for the engineering students responding to this survey 
may have played a role in research identity indication. We also hypothesize that students 
overwhelmingly consider research to be an academic exercise; therefore, students 
participating in more industry-focused experiences may not have associated their specific 
summer activities with research. 
The results suggest that engineering students identify less with research, as 
compared to science students, and subsequently feel less prepared to conduct research; 
however, participation in an interdisciplinary experience increases their indication of 
academic research preparedness. The results show, for the population studied, that 
participation in a research program, such as REM and summer REUs, increases URM 
student research identity which, in turn, could help increase diversity of the research 
population. 
Limitations and Future Directions 
While this work is a good starting point to better understand minority 
undergraduate students’ perceptions of science, engineering and research identity and 
preparedness to conduct research, it is evident that the programs, and therefore the 
surveys, were limited by the small sample size. While this study was intended to assess 
how students participating in the program identify within science, engineering, and 





to better understand how federally-funded and related programs impact students and the 
future of STEM fields. Some limitations of the study related to the identity survey items 
include the adaptation of items and missing data. The survey items have been validated 
and proven reliable for science and math identity through the SaGE study [189]. Further, 
missing data responses were dealt with by deleting entire responses for missing pre- or 
post- results. As for the REM program survey, each student’s perception of the questions 
may have skewed their response to the questions and thus the results of the survey items.  
Future work in this area of study should focus on capturing a larger, more 
representative population of undergraduate researchers. A longitudinal study would be 
insightful to follow up this work in order to see how the identities of science, math, 
engineering, and research change and morph over time with each RP’s experiences and 
beyond, as he/she becomes part of the STEM community. Future work comparing 
research experiences of URMs to those of non-URM students would add insight 
regarding the relationship between ethnicity, gender, or experience level and research 
identity, or regarding the influence of cultural differences (e.g. between English speaking 
countries, other Western countries, and Eastern European or Asian or African countries) 
on identity development. Further work must be conducted to establish the validity and 
reliability of research identity survey items. Based on current literature, science, math, 
and physics identities factor into the development of engineering identity [186]. Future 
research may explore the relationship of these already validated identities with research 





could be done through interviews to better understand student perceptions of research 
identity and their feelings of preparedness for research. 
Summary 
The overall motivation for this work is to increase the number of 
underrepresented minority students pursuing STEM careers which may lead to the 
fulfillment of research and innovation goals for the United States in years to come. It is 
our position that participation in undergraduate research programs fosters the 
development of research identity in both science and engineering students and will allow 
students to feel more prepared to pursue further research opportunities. The program 
highlighted in this work combined “hands-on” experience with faculty and graduate 
student mentoring to develop this research identity. Interest, competence, and recognition 
are critical factors in the development of any type of identity. Survey tools used in this 
study sought to explore the effect of participation in this program on those factors in 
identity development. Results showed that science students and engineering students may 
see their respective areas of study in different lights than their counterparts, but also they 
see research and its connection to their established academic identities as different. 
Science majors seemed to identify highly with only science, while engineering students 
identified with both science and engineering identity items. Science identity seemed to be 
the most direct link to the development of research identity in these students. Based on 
the results from this study, we consider these programs to be a positive and impactful 












The overarching objective of this work had two components; the first was 
technical work focused on developing a 3D in vitro breast tissue model and the second, to 
understand how undergraduate students in Science, Technology, Engineering, and 
Mathematics (STEM) disciplines who participate in research develop a research identity. 
In Chapter 2, it was determined that processing parameters affect the final material 
properties of polylactide beads. Both the vessel size/paddle size and PVA concentration 
have a definitive effect on bead size and shape. These are two processing variables that 
can and should be controlled for the intended application. In choosing beads for the 3D 
breast tissue model, beads with a diameter of 250-325 mm were selected because 1) the 
larger the beads have more mass and anything over 400 mm would not suspend in the 
model and 2) the smaller beads have a more uniform shape providing a more consistent 
model. 
Collagen/Matrigel™ of 2.4 mg/ml was chosen to represent the stromal component 
of the 3D breast tissue model based on their performance reported in Chapter 3. This 
combination provided a MCF10A cell viability above 75%, production of both acinar and 
ductal-like structures and cell cluster measurements consistent with a cluster of 5 or more 
cells providing the most representative model of the normal breast tissue.  
To produce a heterogeneous 3D breast tissue model, polylactide beads were 





measurements, macro and micro mechanical properties, histological analysis of cell 
proliferation, cell-cell adhesion, and acinar and ductile-like structure formation were 
analyzed to assess the feasibility of producing a model system to look at the influence of 
heterogeneity on normal and cancerous mammary epithelial cells. This work 
demonstrates that a heterogenous 3D breast tissue model can be produced incorporating 
degradable, synthetic materials. Further, inclusion of these materials affected acinar and 
ductile-like structure formation, for example, cancerous epithelial cells formed larger 
clusters of disorganized cells, which is more consistent with a breast cancer environment.  
The overall motivation for the educational component of this work is to increase 
the number of underrepresented minority students pursuing STEM careers. This work 
suggests that participation in undergraduate research programs foster the development of 
research identity in both science and engineering students during their first two years of 
undergraduate study. The students felt more prepared to pursue further research 
opportunities after this initial experience. During the program, students received 
mentoring from faculty and graduate students aiding in their development of a research 
identity. These conclusions are drawn from the results of a survey tool designed to assess, 
interest, competence, and recognition, three critical factors in the development of 
engineering, science, and research identity. One difference that was found between 
engineering and science students was that the science majors seemed to identify highly 
with only science, while engineering students identified with both science and 
engineering identity items. Correlations revealed that science identity was connected to 





study, we consider these programs to be a positive and impactful experience for 











RECOMMENDATIONS FOR FUTURE WORK 
 
 
1. Monitoring of 3D structures for this study was challenging. Use of an inverted 
fluorescent microscope works well for histological sections but when imaging full 
3D gels, in the future the use of a confocal microscope is recommended. This will 
allow the capture through multiple microphotographs of the 3 dimensions of the 
acinar and ductal-like structure formation.  
2. Some specific histological staining could be conducted on whole constructs 
allowing analysis of full structures instead of sectioning the structures. However, 
this approach is limited to few stains beside specific immunohistochemistry using 
fluorescent probes. Although, this may allow more accurate cell cluster counts 
and measurements and provide a more comprehensive understanding of cell 
viability and cell organization with H&E stains and routine stain, serial sections 
remains the standard with efforts to develop computer software approaches 
allowing section compilation and 3D rendering. 
3. In the studies conducted constructs were seeded with approximately 120,000 cells 
per well, While these numbers were based on values found in the literature, using 
a ratio of cells to a specific volume or area in the matrix could provide a better 
model. Whether increasing the number of cells seeded in the 3D construct would 
facilitate both physical and chemical cell interactions and potentially promote the 





4. In the process to form the heterogeneous 3D breast CM matrices, the suspension 
of polylactide beads in the Collagen/Matrigel™ was challenging. In the future, a 
gelation method that decreases the amount if time, e.g. crosslinking of the matrix 
materials, would prevent the polylactide beads from settling out of the matrix and 
provide a more uniform distribution of the beads throughout the construct. In 
addition, mechanical testing and histological analyses were affected by the need 
for specific vessels to contain the 3D constructs and the difficulties sectioning 3D 
matrix containing beads. By changing the consistency of the model constructs, 
more accurate mechanical testing could occur. Future research should address 
those limitations. 
5. Polylactide beads were incorporated into the 3D CM matrices to provide both 
heterogeneity and an acidic environment normal within the breast tumor 
microenvironment. Polylactide beads release lactic acid into the surrounding 
matrix as they degrade; however, pH change in the matrix surrounding the beads 
was not evaluated. Further work should explore the effects of pre-degrading the 
beads, the pH changes that occur due to bead degradation, and the effects of the 
acidic environment within heterogeneous 3D CM matrices.  
6. The 3D breast tissue model produced here needs to be validated to ensure the 
model system represents the desired select aspects of the normal breast 
environment, but also can be tuned to represent the different environments seen in 





represent aspects of the normal mammary epithelial environment, however, 
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• 1L Beaker 
• Plastic tubing for transferring beads to rinse bottles 
• IKA Works overhead stirrer with paddle stir rod 
• Syringe (glass not required) with 16 gauge needle 
• Orbital shaker 
• Glass flasks with ceramic insert and filter paper for drying beads with house air 
 
Working Solutions 
• 10% (w/v) PL Solution: 2g PL pellets in 20 mL dichloromethane (Mallinckrodt 
#4879). Leave overnight on orbital shaker at 150 rpm for pellets to go into 
solution. This particular concentration was optimized for Cargill amorphous 
PLLA pellets, so it may differ from the most desirable concentration for the 
particular batch you are using. Two vials of this solution have been used to 
successfully make one batch of beads. 
• 0.3% (w/v) PVA Solution: 3g PVA (MW of 13-23k – Aldrich #36-317-0) in 1000 
mL distilled water. Stir on low heat until PVA dissolves in water. Cool to room 
temperature before using to process beads. 
• 2% (v/v) Isopropanol Solution: 20 mL Isopropanol (VWR #VW5520-3) in 980 




1. Beaker set-up. Place 1 L beaker on stir platform. 
2. Set stirring conditions. Add 150 mL of 0.3% PVA solution to beaker. Make the 
solution 0.05% by adding an additional 750 mL of distilled water to the beaker. 
Position stir rod on overhead stirrer in center of beaker so that the stir rod sits at 
the 300 mL mark on the beaker. Stir at 200 rpm for 5 minutes to ensure thorough 
mixing. 
3. Attach needle to syringe. Remove plunger from syringe. Pour 20 mL of PL 
solution into syringe quickly but carefully. Avoid pouring the solution down the 
side of the syringe – try to pour down the center. Solution on the sides, near the 
top of the syringe, will cause it to seize in a short time making bead production 





syringe, insert plunger. While maintaining slight pressure, turn the syringe over 
and let the air bubbles in the solution float to the top. Remove the air bubbles 
from the syringe by applying gently pressure. Be sure to have a paper towel handy 
to avoid squirting PL solution all over the hood. 
4. Submerge needle of syringe at a 45° angle near (but not in) the stirring vortex at 
the center of the beaker. Try to apply consistent pressure to syringe and dispense 
entire contents of syringe into the stirring PVA solution. 
5. Stir beads in the solution at 300 rpm for 90 minutes. These settings should only be 
used as a guide. Ultimately, the decision is up to you to determine if your beads 
appear to be small enough. Lowering the speed below this range will cause the 
beads to increase in size while increasing the speed will produce beads of smaller 
size. 
6. Turn the overhead stirrer OFF. Allow beads to settle in beaker. Using the house 
vacuum and “bioreactor” bottle top remove the 0.05% PVA solution from the 
beaker leaving approximately 200 mL. 
7. Add 400 mL of 2% Isopropanol solution. Turn overhead stirrer ON, and stir again 
in the 175-200 rpm range for 5-10 minutes. 
8. Turn the overhead stirrer OFF. Allow beads to settle on bottom of beaker. Again 
using the house vacuum, remove the remaining solution.  
9. Move beads to a 250 mL pyrex bottle by pouring the beads into bottle from 
beaker. You may need to use a squirt bottle full of Isopropanol solution to help 
move beads from beaker to bottle. 
10. Add 50 mL of fresh 2% Isopropanol solution to 250 mL pyrex bottle. 
11. Place bottle on orbital shaker overnight (24 hours) at 150 rpm. 
12. Place ceramic insert into top of glass flask. Insert 3” filter paper into ceramic 
insert. Remove the beads from the bottle that was on the orbital shaker, and place 
them on the filter paper. Turn the house air on low flow to slowly dry the beads. 
Remove the beads from the filter paper and store them in 20 mL glass scintillation 











Objective: Use immunofluorescence staining to assess expression of primary and 
secondary antibodies on fixed, frozen sections embedded in OCT. 
 
Materials: 
• 0.2% tween PBS 
• 10% goat serum in PBS 
• 1% goat serum in PBS 
• 1:1600 rat anti-Ecadherin in 1% goat serum 
• 1:200 goat anti-rat Alexa 594 (spun down @ 1000 rpm for 1 min) 
• 1:1000 rabbit anti-Ki67, 1:1000 rabbit anti-CD29, or 1:1000 rabbit anti-met in 1% 
goat serum 
• 1:200 goat anti-rabbit Alexa 488 (spun down @ 1000 rpm for 1 min) 
• ddH2O 
• PBS 
• Pap pen 
• Paper towels 
• Waste container 
• Sectioned samples, embedded in OCT 
 
Protocol: 
1. Draw around each slide using a pap pen to contain rinses to slide 
2. Rinse twice with ~1 mL ddH2O per slide for 2 minutes to remove OCT. Pour 
ddH2O into waste container. 
3. Rinse once with ~1 mL PBS per slide for 2 minutes. Empty into waste container. 
4. Add ~1 mL 1:1 HCl:PBS to each slide for 30 minutes. Empty into waste 
container. 
5. Rinse twice with 0.2% tween PBS for 2 minutes. Empty into waste container 
6. Block with 10% goat serum for 45 minutes at room temperature (RT).  
7. Add rat anti-Ecadherin primary antibody solution for 2 hours at RT.  
8. Rinse with 0.2% tween PBS for 2 minutes. Empty slide(s) in waste. 
9. Add goat anti-rat 594 secondary antibody. Leave overnight in fridge, protected 
from light.   
10. Rinse once with PBS for 2 minutes. Empty slide(s) into waste. 
11. Add second primary antibody (e.g. rabbit anti-Ki67) for 2 hours at RT. Protect 
from light.  
12. Rinse with PBS for 2 minutes. Empty slide(s). 
13. Add second secondary antibody, goat anti-rabbit-alexa 488. Leave overnight in 





14. Rinse twice with ddH20 for 2 minutes. Empty slide(s). 
15. Mount coverslip with Prolong Gold Antifade Reagent + DAPI and store away 
from light. 
	  
 
